Mass Spectrometric Analyses of the Lipidomes of Quiescent and Non-Quiescent Cells Reveal that Certain Dietary, Pharmacological and Genetic Interventions Delay the Chronological Aging of the Yeast Saccharomyces Cerevisiae by Altering Lipid Metabolism by Piano, Amanda
 Mass Spectrometric Analyses of the Lipidomes of Quiescent and Non-Quiescent Cells Reveal 
that Certain Dietary, Pharmacological and Genetic Interventions Delay the Chronological Aging 







 in  





Presented in Partial Fulfillment of the Requirements 
for the Degree of Master of Sciences at 
Concordia University 
 




© Amanda Piano, 2015 
 CONCORDIA UNIVERSITY 
School of Graduate Studies 
This is to certify that the thesis prepared 
By:   Amanda Piano 
Entitled: Mass Spectrometric Analyses of the Lipidomes of Quiescent and Non-Quiescent 
Cells Reveal that Certain Dietary, Pharmacological and Genetic Interventions 
Delay the Chronological Aging of the Yeast Saccharomyces Cerevisiae by 
Altering Lipid Metabolism 
and submitted in partial fulfillment of the requirements for the degree of 
Master of Sciences (Biology) 
complies with the regulations of the University and meets the accepted standards with respect to 
originality and quality. 
 
Signed by the final examining committee: 
________________________________ Chair 
Dr. Selvadurai Dayanandan 
 
________________________________ External Examiner 
Dr. Alisa Piekny 
 
________________________________ Examiner 
Dr. Reginald Storms 
 
________________________________ Examiner 
Dr. Madoka Gray-Mitsumune 
 
________________________________ Supervisor 
Dr. Vladimir Titorenko 
                        
                        Approved by _____________________________________________ 
                                               Chair of Department or Graduate Program Director 
                                               _____________________________________________ 
                                               Dean of Faculty of Arts and Science 




Mass Spectrometric Analyses of the Lipidomes of Quiescent and Non-Quiescent Cells 
Reveal that Certain Dietary, Pharmacological and Genetic Interventions Delay the 
Chronological Aging of the Yeast Saccharomyces Cerevisiae by Altering Lipid Metabolism  
 
Amanda Piano, M.Sc. 
 
Recent studies have revealed that different classes of lipids play essential roles in the intrinsically 
complex process of cellular aging. Although these roles of lipids is blurred by intricacy and 
complexity, the identification of mechanisms that link lipid metabolism to cellular aging is 
currently underway. The investigation of a cell’s entry into and progression through a 
differentiated quiescent state can provide a means of linking cell cycle regulation to aging. Using 
yeast Saccharomyces cerevisiae as a model organism, I explored how the major lipid classes 
phosphatidic acid (PA), phosphatidylethanolamine (PE), phosphatidylcholine (PC), 
phosphatidylinositol (PI) and phosphatidylserine (PS), as well as mitochondria specific 
cardiolipin (CL) and major storage lipid triacylglycerol (TAG), are influenced during the aging 
process by various dietary, pharmacological and genetic interventions known to extend 
longevity. These interventions include a caloric restriction diet, lithocholic bile acid (LCA) and 
the tor1Δ mutation eliminating the key protein component of the pro-aging Target of Rapamycin 
Complex 1 (TORC1) pathway. The quantitation of different lipid classes throughout the entire 
lifespan was accomplished by the mass spectrometric analysis of lipids found in quiescent and 
non-quiescent cell populations separated by centrifugation in a Percoll density gradient. My 
findings revealed that there are at least three different ways of delaying aging in yeast by 
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1 Introduction  
 
1.1 The budding yeast Saccharomyces cerevisiae as an advantageous model organism for 
unveiling mechanisms of cellular aging in multicellular eukaryotes  
The aging process has demonstrated its complexity at both the organismal and cellular 
level. The converging, diverging and overlap of cellular aging pathways and mechanisms, as 
well as the great intricacy at the multicellular level, has contributed to our blurred understanding 
of the complex mechanisms and processes underlying cellular aging in both individual cells and 
cell populations. For this reason, the budding yeast Saccharomyces cerevisiae is arguably one of 
the most important model organisms when conducting age-related research [1, 2, 3] and has been 
recognized as contributing to the identification of the most age-related mammalian genes when 
compared to other model organisms [1]. Our enhanced knowledge of the roles and functions of 
genes in yeast has furthered our understanding of age-related diseases and illnesses and the 
mechanisms with which they manifest in higher eukaryotes such as humans.  Such a great 
advantage over other model organisms is due to budding yeast’s unicellular properties, easy 
ability to culture, maintain and study, and its evolutionarily conserved eukaryotic cellular aging 
processes [4].  S.cerevisiae’s unicellular properties and evolutionarily conserved cellular 
processes and pathways provide a simplified model allowing a deeper understanding of the 
mechanisms and biological principals involved in multi-cellular eukaryotic aging [4]. This 
further insight is due to budding yeast’s tractability to all levels of experimental analysis such as 
genetic, molecular, biochemical, cell biological, system biological and microfluidic dissection 
analysis [3, 5, 6, 7, 8]. The short and easily observed lifespan of S.cerevisiae has played a major 
role in the rapid identification of various molecular mechanisms and factors that modify aging, 




energy-sensing signalling pathways and small molecules in defining and influencing eukaryotic 
longevity [2, 5]. The impact of these longevity influencing factors can be easily assayed due to 
S.cerevisiae’s ability to provide two aging models as complementing approaches to study aging.  
 
1.2  Replicative and chronological models of yeast aging  
An additional advantage when studying yeast as a model organism is aging can be easily 
examined by two different lifespan assays, each monitoring a different aspect of cellular aging 
[1, 9]. Traditionally investigated independently of each other under laboratory conditions, 
replicative and chronological aging lifespan assays are able to provide us with strong models of 
the aging process in both dividing and non-dividing cells respectively [4, 5, 9]. Replicative 
lifespan studies (RLS) take advantage of the asymmetric budding that takes place during yeast 
division in nutrient available environments and defines aging as the number of daughter cells a 
single mother cell can produce before cell cycle arrest [1, 2, 10] (Figure 1.1). Under laboratory 
conditions, replicative lifespan assays involve the manual removal of daughter cells from the 
mother cell using a micromanipulator under a dissection microscope [1, 11]. Smaller daughter 
buds are continuously removed and tallied until the mother cell reaches a post-replicative state, 
no longer able to produce daughter cells (about 20-30 divisions later), becoming senescent and 
eventually lyse [11] (Figure 1.1). RLS with yeast are valuable as they are able to provide a 
cellular aging model for mitotically active cells (for example lymphocytes) in multicellular 
organisms [2, 11]. When studying replicative lifespan in yeast, it is extremely important to note 
that there are multiple factors that can influence yeast’s replicative lifespan such as growth 
conditions (nutrient availability and carbon source) and genetic background [1]. Yeast cells 




extending influence of a calorie restricted diet in multicellular eukaryotic organisms, differ in 
their replicative lifespan extension depending on the genetic background of the strain [1]. 
Findings such as this have demonstrated the significant influence of various environmental and 
genetic factors on replicative aging [1].  
 
Figure 1.1 Replicative and Chronological Lifespan Studies Replicative lifespan is determined 
by the number of mitotic divisions or number of daughter cells a mother cell produces until cell 
cycle arrest. Chronological lifespan is measured by the amount of time during the stationary 
phase/post mitotic phase cells can maintain viability and proliferate when placed on to nutrient-
rich media [1]. 
 
The second yeast aging paradigm investigates chronological lifespan by determining the 
length of time a cell remains viable after cell cycle arrest takes place [1, 2, 11, 12] (Figure 1.1). 
Upon nutrient limitation, yeast cell growth and division are arrested and cells enter the stationary 
growth phase. Chronological lifespan studies (CLS) define lifespan by the amount of time yeast 
cells remain viable while in this non-dividing phase. Yeast cell viability is determined by the 
cell’s ability to re-enter the cell cycle and commence division when essential nutrients are 




9, 12, 13]. Liquid cultures are able to provide post-mitotically active cells arrested in their cell 
cycle, as once all carbon sources are exhausted, the culture enters the stationary growth phase [2, 
4]. Yeast cell viability is determined at various time points throughout stationary phase by the 
ability to resume mitotic growth upon formation of a colony when placed on nutrient rich media, 
thus defining their chronological lifespan [12, 13]. The chronological lifespan model of aging in 
yeast is able to complement that of replicative lifespan as it provides a model that studies non-
dividing cells (for example neurons and stem cells) in multicellular eukaryotic organisms [1, 5]. 
CLS also provide a model to investigate the mechanisms involved in apoptotic and necrotic cell 
death pathways [1, 5]. 
The replicative and chronological aging paradigms have both provided models that 
further investigate different aspects of aging in yeast, each with their own assay. The availability 
of these assays has been able to significantly advance our understanding of the cell-autonomous 
mechanisms responsible for orchestrating longevity-defining cellular processes within an 
individual cell in eukaryotic organisms [1, 2, 8, 10, 14]. 
 
1.3  Cell-autonomous mechanisms underlying chronological aging in yeast S.cerevisiae 
As chronological lifespan studies continue to emerge, there appears to be a wealth of 
information demonstrating that cellular aging is not simply a programmed process of functional 
decline or the accumulation of molecular damage; rather it is made up of a biomolecular network 
composed of longevity-defining processes [5, 9]. These cellular processes include cell 
metabolism, growth, division, organelle biogenesis, interorganellar communication, 
macromolecular homeostasis, stress response and death, all taking place throughout yeast’s 




prior and/or after entry into a non-proliferative state that are responsible for defining the 
longevity of chronologically aging yeast [5]. A biomolecular network is composed of these 
longevity-defining cellular processes and current research suggests several lifespan checkpoints 
play key roles in determining the pace of cellular aging [5, 9]. Yeast’s lifespan consist of both 
early-life (logarithmic, diauxic and post-diauxic growth phase) and late-life (stationary growth 
phase) checkpoints located both prior to and after cell cycle arrest respectively [9]. The 
importance and presence of these checkpoints is exemplified by the addition of a longevity 
extending molecule only exhibiting its anti-aging effect if added at a specific checkpoint during 
yeast’s lifespan, supporting the importance of these lifespan checkpoints in defining longevity 
based on the anti- or pro- aging influence on the cellular processes [5, 15]. Each checkpoint 
involves master regulator proteins, responsible for assessing the intracellular concentrations of 
intermediates and by-products of certain metabolic pathways, and are then able to respond to 
these intracellular conditions by influencing the rates and efficiencies the cell’s cellular processes 
(Figure 1.2). Master regulator proteins are therefore responsible for regulating vital cellular 
processes throughout chronological lifespan by orchestrating the development and maintenance 
of anti- and pro- aging cellular patterns to establish a rate of chronological aging and define yeast 
chronological lifespan [9]. The concentration of intracellular key metabolites is influenced by 
factors such as diet and the addition of small molecules [5, 9]. Master regulator proteins detect a 
change in the concentration of key metabolites at given checkpoints and respond by modulating 
the rate of cellular processes, such as cell growth, division, metabolism or stress response in the 
network, in turn establishing the rate of chronological aging (Figure 1.2). Key proteins and 
protein complexes that play roles as checkpoint-specific master regulators include but are not 




stress resistance, 2) Tel1p and Rad53p as anti-aging master regulators by their ability to 
minimize telomere DNA damage and 3) TORC1 (Target of Rapamycin Complex 1) as a pro-
aging master regulator [5] (Figure 1.2). An increase in the intracellular amino acids synthesized 
from Tricarboxylic acid (TCA) cycle intermediates, activates the TORC1 complex leading to a 
pro-aging cellular pattern involving protein synthesis in the cytosol, inhibition of stress genes, 
suppression of protein synthesis in the mitochondria and the suppression of autophagy (via 


































Figure 1.2 The concept of a biomolecular network underlying chronological aging in yeast. 
The concept of a biomolecular network includes both early (logarithmic phase (L phase), diauxic 
phase (D phase) and post-diauxic phase (PD phase)) and late (stationary phase (ST phase)) 
lifespan checkpoints. The intracellular concentrations of key intermediates and products of 
longevity-defining metabolic pathways are monitored by master regulator proteins or protein 
complexes. These master regulators then respond to age-related intracellular concentrations of 
key metabolites at specific time points by adjusting the rate and efficiency of cell metabolism, 
growth, division, organelle biogenesis, interorganellar communication, macromolecular 
homeostasis, stress response or death. The regulation of these cellular processes throughout 
lifespan orchestrates the development and maintenance of anti-aging (red) or pro-aging (blue) 
cellular patterns, therefore establishing the rate of cellular aging and defining yeast chronological 
lifespan. Anti-aging master regulators are located in the red circles and pro-aging master 








1.4  Differentiation of yeast cells cultured in liquid media yields several cell populations 
that differ in their longevities  
As previously mentioned, stationary-phase yeast cultures play a crucial role in the 
analysis of chronologically aging yeast cells as it provides post-mitotic cells that can be assayed 
for their viability.  When cultured in nutrient-rich liquid media with glucose, yeast cells consume 
glucose as their primary carbon source and cell division takes place at an exponential rate [3, 4]. 
Upon glucose exhaustion, cells begin to cease rapid growth and begin to utilize non-fermentable 
carbon sources in the medium, leading to the diauxic shift [3, 4]. During the diauxic shift, the 
culture transitions from the logarithmic to diauxic growth phase and yeast cells begin to arrest in 
the G1 phase of the cell cycle (G0 state) allowing them to enter a differentiation program 
yielding a population of non-proliferating quiescent cells [4, 9, 16, 17].  
Quiescent cells are infamously known for their ability to synchronously re-enter the cell 
cycle and commence cell division when placed back into nutrient rich conditions [4, 16, 17, 18]. 
Upon entry into the stationary phase, an environment of carbon exhaustion/starvation, yeast 
cultures are composed of both quiescent cells and a heterogeneous mixture of non-quiescent cells 
[4, 16, 17]. Differentiation into a quiescent state provides quiescent cells with various physical, 
physiological and biochemical characteristics displaying the reprogramming and remodelling of 
most intracellular structures and processes [3, 4, 16, 17]. The quiescent cell population is 
composed of mainly unbudded daughter cells or young mother cells that have only budded once, 
with a thickened cell wall, uniform in size and maintain a higher density than non-quiescent cells 
[16, 17]. The significant difference in density allows the easy separation of the two cell 
populations by density centrifugation [16, 17]. The accumulation of reserve carbohydrates such 




17, 18]. The increase of intracellular trehalose, a non-reducing disaccharide, provides the cell 
with the ability to survive situations of desiccation and freezing [18]. Trehalose accumulation 
contributes to the stress tolerance of cells by preserving membranes in a liquid crystalline phase 
as well as stabilizing proteins and preventing their aggregation during heat shock [18]. Quiescent 
cells have shown resistance to various types of stresses including: chronic oxidative, thermal and 
osmotic stress while maintaining functional mitochondria with a high respiratory efficiency and 
low levels of reactive oxygen species (ROS) [16, 17]. The maintenance of viability (determined 
by high metabolic activity when monitored with a fluorescent reporter molecule), reproductive 
capacity (determined by the cell’s ability to form colonies on fresh media) and genomic stability 













Figure 1.3 Model of quiescent (Q) and non-quiescent (NQ) cell differentiation during 
diauxic shift in glucose rich medium. During Post-diauxic and stationary phase, both quiescent 
and non-quiescent cell populations are present. Non-quiescent cells are comprised of three cell 
types, varying in their reproductive competence and viability, which are replenished at a slower 
rate by age-related differentiation of quiescent cells [4]. Figure Reference [4]. 
 
The stationary phase’s non-quiescent cell population is comprised of old mother cells that 
have budded multiple times [4, 5, 16]. The less dense non-quiescent cell population is a 
heterogeneous mixture of cells that vary in viability and reproductive competence [4, 16, 17] 
(Figure 1.3). This heterogeneous mixture is made up of 3 cell types which include 1) viable and 
reproductively competent cells that begin to exhibit genomic instability, high levels of ROS and 
mitochondria that are unable to respire; 2) viable but reproductively incompetent cells that are 
believed to derive from the previously mentioned viable, reproductively competent non-
quiescent cells and lastly; 3) apoptotic and senescent cells that may have originated from the 
reproductively incompetent non-quiescent cells [4, 16, 17] (Figure 1.3). Quiescent cells, under 




slower rate as they begin to lose their quiescent cell characteristics such as genomic stability, 
mitochondrial function, reproductive competence and viability [4, 19] (Figure 1.3).  
Quiescent cells maintain their viability and reproductive competence for a longer period 
of time when compared to non-quiescent cells due to the numerous structural, metabolic and 
physiological features that quiescent cells acquire upon their differentiation during the diauxic 
shift. Nutrient availability plays an important role in the differentiation of quiescent cells as 
quiescent cell differentiation takes place once the cell is faced with a nutrient limited and 
stressful environment.  
  
1.5  The characteristic structural, metabolic and physiological features of quiescent 
yeast cells are orchestrated by a network of nutrient-sensing signalling pathways 
As previously established, quiescent yeast cells undergo a drastic remodelling of their 
characteristics at the morphological, biochemical and physiological level upon exit from the cell 
cycle during the G1 phase in nutrient starved conditions [18]. These quiescent cell traits provide 
cells with the ability to survive long periods of starvation or stress and re-enter the proliferating 
state upon re-feeding [18]. Key nutrient-sensing pathways ensure quiescent cells acquire and 
maintain their quiescent-cell characteristics better adapting them to nutrient limited or stressful 
environments increasing their chances for survival [18]. The evolutionarily conserved core 
nutrient signalling pathways that ensure proper entry into quiescence and the acquiring of 
quiescent cell characteristics includes the Protein Kinase A (PKA), Target of Rapamycin 
Complex 1 (TORC1), Sucrose non-fermenting 1 (Snf1) and Pho85 signalling pathways [18]. 
These key signalling pathways display several points of overlap that ensure the appropriate 




The PKA signalling pathway plays an important role as a positive regulator of cellular 
growth and a critical player in deciphering when to enter quiescence [18]. The heterotetrameric 
protein kinase PKA complex includes 2 catalytic subunits with 2 regulatory subunits acting as 
pseudosubstrates [19, 20]. The presence of cAMP (cyclic-adenosine monophosphate), in glucose 
rich environments, causes the regulatory subunits of PKA to bind cAMP therefore releasing 
PKA’s catalytic subunits, allowing the phosphorylation of target proteins involved in ribosomal 
biogenesis, cellular growth, stress response and metabolism [18, 19]. PKA-signalling network 
promotes growth by inducing ribosome biogenesis by way of the controlled expression of 
ribosomal protein genes, rDNA genes and Ribi (ribosomal biogenesis) genes while inhibiting 
transcription factors that repress growth [18]. Upon glucose exhaustion, decreasing levels of 
cAMP lead to the negative regulation of the PKA pathway [18, 19]. The down regulation of PKA 
leads to the expression of genes associated with stress resistance, the inhibition of cell growth 
and cell cycle progression by the regulation of G1-S phase progression and the inhibited 
mobilization of reserve carbohydrate glycogen and stress protecting trehalose, allowing 
quiescent yeast cell to obtain their characteristics essential for proper entry into a quiescent state 
[18, 19]. Yeast cells with uncontrolled PKA activity are unsuccessful in acquiring most 
physiological characteristics of quiescent cells upon entry into stationary phase, while PKA 
deficient yeast cells are locked into a G0-like state as growth is arrested, demonstrating the 
critical role of PKA upon entry into quiescence [18]. 
TORC1 is a highly conserved pro-aging pathway in yeast that plays a critical role in the 
cell’s decision on when to enter quiescence [18]. TORC1 activity relies on both the quality and 
quantity of multiple nutrients in the environment and can be inhibited by various environmental 




stress such as acetic acid, high salt, redox stress or high temperatures [18, 21]. The TORC1-Sch9 
nutrient signalling branch of the TORC1 pathway plays an important role in lifespan regulation 
during chronological aging as the deletion of protein kinase SCH9 in yeast mimics the longevity 
extending effects of a calorie restricted diet and a TOR1 deletion [21]. Upon starvation for 
essential nutrients such as carbon, nitrogen or phosphate, yeast cells arrest growth and division, 
and then enter into the stationary phase [21]. TORC1’s inhibition mimics the effects of nutrient 
starvation as they both lead to decreased protein synthesis and ribosomal biogenesis, changes in 
gene transcription, induction of autophagy, G1 cell cycle arrest and entry into quiescence [18, 
21]. 
The Snf1 protein kinase signalling pathway is a central controller of energy homeostasis 
largely dependent on the presence of glucose [18, 19, 20]. The presence of glucose causes the 
auto-inhibition between the catalytic and regulatory subunits of Snf1p, a heterotrimeric AMP-
activated kinase at the centre of the Snf1 pathway, inactivating its protein kinase function [19, 
20]. The absence of glucose relieves this inhibition allowing Snf1p to be a functional protein 
kinase. Snf1p activation under declining glucose levels, promotes respiratory metabolism, 
gluconeogenesis, glycogen accumulation, autophagy and peroxisome biogenesis due to its ability 
to take part in the transcription of 400 genes, either by inhibiting transcriptional repressors or 
stimulating transcriptional activators, along with controlling transcriptional machinery [18, 20]. 
During the diauxic shift, when the preferred carbon source (glucose) is depleted, Snf1p plays a 
critical role in ensuring the expression of numerous genes involved in the metabolism of 
alternative carbon sources, such as gluconeogenesis and respiration, ensuring the yeast cell 
acquires the appropriate metabolic machinery and traits as a quiescent cell maintaining viability 




is important upon entry into quiescence as it provides the cell with the appropriate metabolic 
machinery and cellular traits to maintain viability and increased chances for survival throughout 
stationary phase.   
The cyclin-dependent kinase (CDK), Pho85, plays a major role in regulating intracellular 
phosphate metabolism but has also demonstrated an important role in other cellular processes 
such as sensing other environmental changes and cell cycle control [19, 20]. Pho85 associates 
with 10 cyclins, directing it to various target substrates [18, 19, 20]. Pho80, the best studied 
cyclin, makes up the Pho80-Pho85 cyclin-CDK complex which in the presence of external 
phosphate inhibits phosphate starvation and the secretion of phosphatases which retrieve and 
metabolize extracellular phosphate from phosphate limited environments [18, 19, 20]. The 
Pho80-Pho85 complex can also activate cyclin Cln3, allowing the progression over START in 
G1 of the cell cycle in phosphate rich environments [20]. Therefore, the inactivity of the Pho80-
Pho85 complex in phosphate deprived conditions prior to entry into quiescence leads to G1 cell 
cycle arrest.  
The proper preparation of a yeast cell structurally, metabolically and physiologically is 
crucial for the cell’s survival when placed in nutrient-limited or stressful environmental 
conditions. Extracellular environmental conditions play a critical role upon entry into 
quiescence. Nutrient conditions outside the yeast cell are relayed by a major complex and 
intricate network of signalling pathways into the cell to allow the cell’s preparation for the best 
chances of survival. The evolutionarily conserved PKA, TORC1, Snf1 and Pho85 signalling 
pathways have all demonstrated a much greater regulatory role upon entry into quiescence in 
addition to their better known roles in cellular energy and building. The integration and overlap 




and entry into quiescence [18] (Figure 1.4). These pathways converge at key nodes by common 
target proteins which play a critical role in the proper establishment of the quiescent program, 
ensuring the best chances of survival for the cell under nutrient starved and stressful conditions 
(Figure 1.4). 
 
Figure 1.4 Key nutrient-signalling pathways converge at critical key nodes ensuring the 
proper establishment of a quiescent program. The key evolutionarily conserved nutrient-
signalling pathways PKA, TORC1, Snf1 and Pho85 share common target proteins (grey circles) 
that play important roles in cell growth and nutrient stress response. The overlap of positive 
(arrows) or negative (bars) interactions ensures the appropriate cellular response to nutrient 
starvation, ensuring the cells best chance of survival. Figure and legend reference [18]. 
 
 
1.6  Synthesis, turnover and regulation of different lipid classes in yeast cells  
Lipids have demonstrated greater roles in the cell in addition to their commonly 
associated roles in energy storage and as structural elements of yeast. Lipids play critical roles in 
cellular processes such as mediators of membrane fusion, apoptosis, cell signalling, membrane 
trafficking, anchoring membrane proteins, reservoir of 2nd messengers, provide pre-cursors of 
macromolecules, modification of membrane association and function as molecular chaperones 




highly conserved eukaryotic lipid pathways which display a strong homology with higher 
eukaryotes [22, 23, 24]. The investigation of lipid biosynthesis, degradation and storage while 
aiding in the determination of the gene-enzyme relationship and how they influence lipid 
synthesis and turnover in multi-cellular organisms is possible due to yeast as a simplified model 
organism [22]. Glycerophospholipid synthesis in yeast is a complex dynamic process that is 
regulated by genetic and biochemical mechanisms and is tightly interrelated with the synthesis 
and regulation of other major glycerophospholipid classes [23]. 
Major yeast membrane glycerophospholipids include phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylinositol (PI), and phosphatidylserine (PS) while 
major mitochondrial membrane glycerophospholipids include phosphatidylglycerol (PG) and 
cardiolipin (CL), demonstrating the cell’s non-uniform lipid distribution and the varying 
glycerophospholipid profile of organelles dependant on the organelle’s structure or function [23, 
25]. Triacylglycerols (TAG) and the sterol esters (SE) are the primary constituents at the core of 
the Lipid Droplet (LD), a storage organelle composed of a monolayer of phospholipids and a 
small amount of proteins that house these neutral lipids [24]. The accumulation of free fatty acids 
(FFA) and sterols can have toxic effects on the yeast cell; therefore they are converted to TAG 
and SE respectively and stored in the LD to avoid this toxic result [24]. Neutral lipids are not 
suitable as membrane components therefore they remain in the LD until they are required by the 
cell for energy or as a precursor of membrane lipid synthesis [24].  
Lipid synthesis takes place in multiple cellular organelles such as the endoplasmic 
reticulum (ER), mitochondria and lipid droplet, but all glycerophospholipid and TAG synthesis 
requires PA as a precursor [22, 23, 24]. Phospholipid and TAG synthesis branch off into 2 major 




(diacylglycerol) respectively [22, 23, 24]. CDP-DAG, a liponucleotide intermediate, acts as a 
direct precursor in the synthesis of PI and PS in the ER [22, 24]. Further modification of PS in 
the mitochondria allows the synthesis of PE [22, 24]. PE is then available for the ER directed 
synthesis of PC, demonstrating a highly interrelated lipid synthesis pathway within the cell as the 
synthesis of one lipid at times relies on the presence of one or multiple lipids as a precursor [22, 
24]. CDP-DAG is also a precursor of CL synthesis in the mitochondria with PG as its precursor 














Figure 1.5 Major yeast lipid synthesis pathways and their subcellular localization. All 
glycerophospholipid and TAG (triacylglycerol) synthesis shares PA as common precursor. The 
CDP-DAG (CDP-diacylglycerol) lipid synthesis branch leads to the direct synthesis of PI 
(phosphatidylinositol) and PS (phosphatidylserine) in the ER (endoplasmic reticulum). PS 
synthesis allows the synthesis of PE (phosphatidylethanolamine) in the mitochondria, which can 
then serve as a precursor for the synthesis of PC (phosphatidylcholine) in the ER. PC and PE can 
also be synthesized via the Kennedy Pathway in the presence of DAG and exogenous choline 
and ethanolamine. CDP- DAG is also the precursor of PG (phosphatidylglycerol) in the 
mitochondria, eventually leading to the synthesis of CL (cardiolipin) after a few modifications. 
The DAG branch from PA leads to the synthesis of TAG in the ER, eventually packaging TAG 
into LDs (lipid droplets) where it is readily available as a source of DAG to refuel the cell with 
PA or provide a source of FFA (free fatty acids) for lipid synthesis or β-oxidation. Figure and 
legend reference [22]. 
 
The second biosynthetic lipid pathway requires PA’s highly regulated dephosphorylation 
to DAG within the ER as a necessary step required for the synthesis of PC and PE by the 
Kennedy Pathway, and as the precursor of TAG synthesis [22, 24]. PC and PE are also derived 
by the Kennedy Pathway in the presence of DAG using exogenous choline and ethanolamine, 
respectively, should the cell have faulty enzymes or lack the necessary precursors to synthesize 




budding off of LDs from the ER [24]. The few proteins in the LD’s phospholipid monolayer 
membrane have been identified as enzymes involved in lipid metabolism [24]. The quantity of 
LDs is dependent on the amount of TAG and SE synthesized, as an increase in their synthesis 
leads to an increase in the number of LDs [24]. Once TAG is sequestered in the LD, it is readily 
available for degradation to DAG and FFA, providing a source of DAG which can be 
phosphorylated to regenerate PA or act as a precursor to PC and PE synthesis via the Kennedy 
pathway [24] (Figure 1.5). The regeneration of PA can then provide the core precursor to further 
the synthesis of all lipids in the CDP-DAG lipid biosynthetic branch. TAG degradation in the LD 
therefore allows the synthesis of most major lipid classes via PA regeneration, and provides the 
cell with FFAs that are important for lipid synthesis and can enter the catabolic process of β-
oxidation to fuel the TCA cycle [24]. 
The tight control of lipid synthesis plays a critical role in the cell as one missing enzyme 
or precursor leads to a cascade of events in the cell if there is no alternative route of synthesis 
available, such as the Kennedy Pathway in the synthesis of PC and PE. The interconnected lipid 
synthesis pathways also provide mechanisms that influence lipid turnover, such as the tightly 
controlled conversion of DAG back to PA, and vice versa, that can fuel both branches (CDP-
DAG and DAG) of lipid synthesis from PA depending on various factors responsible for 
regulating lipid synthesis [24]. 
Glycerophospholipid synthesis can be regulated by various factors such as enzyme 
expression or the regulation of an enzyme’s catalytic activities [24]. The presence of both 
specific and non-specific phospholipases and phosphatases play a critical role in lipid regulation 
by contributing to the turnover of lipids by way of their degradation [24]. Gene expression of 




such as temperature, growth medium, pH and nutrients [24]. This demonstrates the crucial role a 
cell’s environmental conditions have on its cellular lipidome. Glycerophospholipid synthesis also 
relies on the phosphorylation of enzymes by protein kinases A and C, casein kinase II and 
cyclin-dependent kinase demonstrating an overlap between various signalling pathways and lipid 
synthesis [24]. With yeast’s lipidome so amendable to environmental changes and influenced by 
various factors such as dietary changes and the addition of small molecules, changes in yeast’s 
lipidome are expected [25]. 
 
1.7  Caloric Restriction (CR) and lithocholic acid (LCA) extend longevity of 
chronologically aging yeast in part by altering lipid metabolism 
Lipid metabolism in yeast is a very dynamic and interrelated network due to the overlap 
of lipid synthesis pathways and the tightly controlled turnover rates between various lipid 
classes. Environmental and nutrient conditions play an important role in lipid metabolism as 
altering these conditions has an influence on the yeast lipidome as a whole [25]. Therefore, a 
change in diet, the addition of a small molecule or a change in genetic background has the power 
to alter the yeast lipidome, demonstrating its flexibility. A calorie restricted diet and the addition 
of lithocholic acid (LCA), a hydrophobic small molecule bile acid, have demonstrated longevity 
extending effects in chronologically aging yeast by altering the metabolism and interorganellar 
transport of lipids [26]. The lipid dynamics of peroxisomes, lipid droplets, mitochondria and the 
ER have demonstrated key roles as players in longevity-extension under a calorie restricted diet 
and/or treatment with LCA [26, 27]. 
Caloric restriction (CR) involves a low-calorie dietary regimen capable of extending 




optimal glucose concentration that promotes the longest lived and most fit chronologically aging 
yeast has shown to be 0.2% [27]. A CR diet, conditions of 0.2% glucose, is capable of regulating 
longevity by various ways such as extending the chronological life span of yeast, remodelling the 
metabolism of trehalose and glycogen, modulating the oxidation-reduction processes in 
mitochondria and ROS levels, altering mitochondrial morphology, delaying mitochondria-
controlled apoptosis, altering the abundance of numerous proteins involved in carbohydrate and 
lipid metabolism while promoting the consumption of neutral lipids deposited in lipid droplets 
[27]. 
Under non-CR conditions of 2% glucose, an increased glucose concentration increases 
intracellular ethanol synthesis upon glucose fermentation, provoking the suppression of 
peroxisome oxidation of FFA due to the lipolysis of TAG in LDs [27, 28]. The suppression of 
FFA oxidation allows the build-up of FFA in the LD, eventually leading to several negative 
feedback loops that induce the accumulation of DAG and FFA in the ER, the location of TAG 
synthesis [28]. This lipid accumulation within the ER leads to pre-mature aging and death of the 
cell due to the accelerated rate of necrosis [28]. Under conditions of calorie restriction, 0.2% 
glucose, lower levels of glucose evade the accumulation of ethanol within the cell, therefore 
averting the suppression of the peroxisomal oxidation of FFAs [28]. A CR diet avoids the 
negative feedback loops that result from FFA accumulation in the peroxisome, evading the 
accumulation of FFA and DAG in the ER [28]. The lack of this lipid accumulation in the 
peroxisome, LD and ER under CR conditions, avoids the accelerated necrosis found under non-
CR conditions, therefore extending lifespan.  
The hydrophobic bile acid, lithocholic acid (LCA), was identified as a powerful 




[28, 29]. The method of LCA’s lifespan extending influence has shown to be independent of any 
major pro-aging pathways such as TOR and cAMP/PKA, as a deficiency in either of these 
pathways will not hinder LCA’s longevity extending ability [28, 29]. LCA treatment has shown 
to remodel the cell’s lipid dynamics under a CR diet by: 1) stimulating mitochondrial transport 
of acetyl-CoA, therefore limiting its availability for FFA synthesis in the ER; 2) activating TAG 
synthesis from FFA and DAG and in the ER and; 3) slowing down the lipolytic conversion of 
TAG into FFA and DAG within the LD [28]. All these cellular modifications to the lipid 
metabolism and synthesis by LCA avert the accumulation of FFAs in the cell, avoiding the pre-
mature aging by necrosis and extending lifespan [28].  
LCA localizes to the inner mitochondrial membrane (IMM) leading to the remodelling of 
the mitochondria’s phospholipid synthesis and transport upon treatment of the cell [30]. These 
changes in the mitochondrial membrane include an increase in PA, PC, PS, and PG with a 
decrease in PE and CL [30]. The yeast cell’s mitochondria also undergo an increase in size and 
decrease in number and IMM cristae [30]. These physical changes in the mitochondria brought 
about by treatment with LCA lead to a more efficient mitochondrial respiration, membrane 
potential maintenance and ATP synthesis as chronologically old quiescent cells age, leading to 










1.8  The objectives of studies described in this thesis 
The differentiation pathways of quiescent and non-quiescent cells have shown to be 
influenced by multiple factors such as dietary, pharmacological and genetic intervention. A 
caloric restricted diet and the addition of the longevity extending molecule lithocholic acid 
(LCA) have shown to increase the lifespan of both quiescent and non-quiescent cells. The 
TORC1 signalling pathway, a key pathway accelerating aging in yeast, has also demonstrated an 
important role in cell cycle regulation and aging. The single-gene-deletion mutation for tor1∆, 
which eliminates the essential Tor1p of the TORC1 protein complex, has been found to extend 
the lifespan of chronologically aging yeast under both CR and non-CR conditions, in synergy 
with the addition of LCA. With our current understanding of how these factors influence the cell 
cycle regulation with respect to quiescent and non-quiescent cells, it is possible to further 
examine how these factors alter yeast’s cellular lipidome to better understand the impact of the 
lipidome on the aging process. 
The mass spectrometric analysis and quantitation of major lipid classes PA, PC, PE, PI, 
PS, CL and TAG in the cell will lead to a more thorough understanding of how lipid metabolism  
influences the aging and differentiation process of quiescent and non-quiescent cells separated by 
density-gradient centrifugation.  
Therefore, my first objective was to elucidate how a calorie restricted diet influences the 
lipidomes of quiescent and non-quiescent yeast cells that age chronologically. 
My second objective was to investigate the effect of the longevity extending small 
molecule lithocholic acid (LCA) on the lipidomes of quiescent and non-quiescent yeast cells 




My third objective was to examine how the TORC1 pathway, a key pro-aging signalling 
route, impacts the lipidomes of quiescent and non-quiescent yeast cells that age chronologically.  
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2 Caloric restriction, a longevity-extending dietary intervention, alters lipid 
compositions of quiescent and non-quiescent cells of chronologically aging yeast 
 
2.1 Abstract 
 A diet known as caloric restriction (CR) has been shown to extend longevity of 
chronologically aging yeast [27, 28]. In studies described in this Chapter of my thesis, I used 
centrifugation in a Percoll density gradient to separate quiescent (Q) and non-quiescent (NQ) 
cells of chronologically aging yeast. The Q and NQ populations of cells were purified from yeast 
cultured either under CR conditions in 0.2% glucose or under non-CR conditions in 2% glucose. 
I employed quantitative mass spectrometry to monitor how the CR diet impacts age-related 
changes in the lipid compositions of purified populations of Q and NQ yeast. My findings imply 
that CR causes a substantial remodeling of lipid metabolism and transport in both Q and NQ 
cells. Based on these findings, I propose a working hypothesis on how CR delays chronological 
aging of yeast cells by altering lipid dynamics within different cellular organelles.      
 
2.2 Materials and Methods 
Yeast strains, media and growth conditions 
The wild-type strain Saccharomyces cerevisiae BY4742 (MATα his3∆1 leu2∆0 lys2∆0 
ura3∆0) from Thermo Scientific/Open Biosystems was grown in YEP medium (1% yeast 
extract, 2% peptone; both from Fisher Scientific; #BP1422-2 and #BP1420-2, respectively) 
initially containing 0.2% or 2% glucose (#D16-10; Fisher Scientific) as the carbon source. Cells 
were cultured at 30oC with rotational shaking at 200 rpm in Erlenmeyer flasks at a “flask 
volume/medium volume” ratio of 5:1. 
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Separation of Q and NQ cells by centrifugation in Percoll density gradient 
1 mL of 1.5 M NaCl (#S7653; Sigma) was placed into a 50-mL Falcon tube, and 8 mL of 
the Percoll solution (#P1644; Sigma) was added to this tube. The NaCl and Percoll solution was 
then mixed by pipetting. To form two Percoll density gradients, 4 mL of the NaCl/Percoll 
mixture was put into each of the two polyallomer tubes for an MLS-50 rotor for an Optima MAX 
ultracentrifuge (all from Beckman Coulter). The tubes were centrifuged at 25,000 × g (16,000 
rpm) for 15 min at 4oC in an Optima MAX ultracentrifuge. A sample of yeast cells were taken 
from a culture at a certain time point. A fraction of the sample was diluted in order to determine 
the total number of cells per mL of culture using a hemacytometer (#0267110; Fisher Scientific). 
For each Percoll density gradient, 1  109 yeast cells were placed into a 15-mL Falcon tube and 
pelleted by centrifugation at 5,000 rpm for 7 min at room temperature in a Centra CL2 clinical 
centrifuge (Thermo IEC). Pelleted cells were resuspended in 500 μL of 50 mM Tris/HCl buffer 
(pH 7.5), overlaid onto the preformed gradient with a syringe and needle to avoid disrupting the 
gradient, and centrifuged at 2,300 × g (5,000 rpm) for 30 min at 25oC in an Optima MAX 
ultracentrifuge. The upper and lower fractions of cells were removed with a micropipette, 
discarding the gradient with no visible band of cells and Percoll was removed by washing cells 
twice with 50 mM Tris/HCl buffer (pH 7.5) and cells were resuspended in 1 mL of 50 mM 
Tris/HCl buffer (pH 7.5) for cell counts and preparation for freezing of the cell pellet.  
 
Cell number measurement of Q and NQ cells separated by centrifugation in Percoll density 
gradient and preparation of pellet for storage until lipid extraction 
A 50 µL aliquot of the upper or lower fraction of cells recovered and washed from the 
Percoll gradient were diluted in order to determine the total number of cells per fraction using a 
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hemacytometer (#0267110; Fisher Scientific). 10 µL of serial dilutions (1:10 to 1:103) of cells 
were applied to the hemacytometer, where each large square is calibrated to hold 0.1 µL. The 
number of cells in 4 large squares was then counted and an average was taken in order to ensure 
greater accuracy. The concentration of cells was calculated as follows: number of cells per large 
square  dilution factor × 10 × 1,000 = total number of cells per mL of fraction. The remaining 
950 µL of the cell aliquots were washed twice with 155 mM ammonium bicarbonate (pH 8.0) in 
preparation for the freezing of the cell pellet at -80ᴼC until the lipid extraction.  
 
Lipid extraction from purified populations of Q and NQ cells 
The lipid extraction of purified populations of quiescent and non-quiescent cells used 
Richard et al.’s modified version of Bligh and Dyer’s lipid purification and extraction protocol 
[31]. The pelleted cell fractions kept at -80ᴼC were thawed on ice before being resuspended in 
1mL of cold nanopure water. The volume that contained 5 × 107 cells of each fraction was 
transferred to the appropriate 15-mL high-strength glass screw top centrifuge tube with a Teflon 
lined cap (#0556912; Fisher Scientific). The volume of each sample was topped off to 1 mL with 
cold nanopure water. To each tube the following was added: 20 µL of the internal standard mix 
prepared in Chromasolv HPLC (>99.9%) chloroform (Sigma-Aldrich) (Table 2.1), 800 uL of 
425-600 µM acid-washed glass beads to break open the cells (#G8772; Sigma-Aldrich) and 3 
mL of a Chromasolv HPLC (>99.9%) chloroform: methanol mixture (both from Sigma-Aldrich) 
at a 17:1 ratio. The samples were then vortexed vigorously for 2 hours at 4ᴼC. At room 
temperature, the samples were then centrifuged in a Centra CL2 clinical centrifuge for 5 minutes 
separating the upper aqueous and lower organic phase which contained nonpolar lipids TAG, 
PC, PE and PG. The lower organic layer was transferred to another labelled 15 mL glass high-
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strength centrifuge tube using a glass Pasteur pipette with careful attention not to disrupt the 
glass beads or upper aqueous phase. 1.5 mL of 2:1 chloroform: methanol solution was added to 
the remaining upper aqueous phase allowing the separation of polar lipids PA, PS, PI and CL. 
The samples were again vortexed vigorously at 4ᴼC for 1 hour. The non-polar organic band was 
kept at 4ᴼC for the duration of the second vortexing. At the end of 1 hour, the samples were 
again centrifuged for 5 minutes at 3,000 rpm and the lower organic phase was separated and 
added to the corresponding non-polar organic phase with a glass Pasteur pipette. With both lower 
organic phases combined, the solvent was evaporated off by nitrogen gas flow. Once all solvent 
was evaporated, the remaining lipid film was dissolved and resuspended in 100 µL of 1:2 
chloroform: methanol and immediately transferred into 2 mL glass vials with Teflon screw tops 
to avoid evaporation until samples were analysed by mass spectrometry. Samples were then 




Table 2.1: Internal standard mix composition (modified from reference [31]) 
 
Internal Standards CL, PA, PE, PG, PS and PC are all from Avanti Polar Lipid, Alabaster, AL, 









number double bonds 
on fatty acid chain) 








in mix                    
(mg/µL) 
Negative 
CL 14:0 / 14:0 / 14:0 /14:0 1274.9000 619.4157 0.10 
FFA 19:0 298.2872 297.2711 0.02 
PA 14:0 / 14:0 614.3920 591.4026 0.10 
PE 14:0 / 14:0 635.4526 634.4448 0.10 
PG 14:0 / 14:0 688.4290 665.4394 0.10 
PS 14:0 / 14:0 701.4240 678.4271 0.02 
Positive TAG 13:0 / 13:0 / 13:0 680.5955 698.6299 0.10 PC 13:0 / 13:0 649.4683 650.4761 0.10 
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Lipid identification and quantitation of Q and NQ cells using mass spectrometry 
 
Samples were diluted 1:1 with 1:2 chloroform: methanol and 0.1% ammonium hydroxide 
for improved ionization efficiency. Samples were injected one at a time using a Thermo Orbitrap 
Velos Mass Spectrometer equipped with HESI-II ion source (Thermo Scientific) at a flow rate of 
5 µL/ minute. The instrument settings for the Orbitrap used the optimized settings listed in 
Richard’s et al.’s tune file (Table 2.2).  
 
Table 2.2: Thermo Orbitrap Velos mass spectrometer’s tune file instrument settings (from 
reference [31]) 
 
Instrument polarity Positive Negative 
Source voltage (kV) 3.9 4 
Capillary temperature (ᴼC) 275 275 
Sheath gas flow 5 5 
Aux gas flow 1 1 
FT-MS injection time (ms) 100 500 
FTMS microscans 3 1 
 
Data was acquired according to the Instrument Method for data-dependent acquisition for 
5 minutes in both positive and negative mode by the FTMS analyser at a resolution of 100,000 
















Table 2.3: Instrument method for data-dependent acquisition (from reference [31]) 
 
Acquisition time                                  5 minutes ( with a 0.25 minute delay) 
Instrument polarity Positive Negative 




















































Between each sample, the line was flushed with 1:2 chloroform: methanol until the 
background ion detection steadied and returned back into the baseline level. Diluted internal 
standard mix was injected multiple times throughout the acquisition to ensure no sensitivity loss 
throughout the run. 
Once all data was acquired, raw files were converted to open mzXML format using 
ProteoWizard MSConvert software (http://proteowizard.sourceforge.net/), the file format used 
by the Lipid Identification Software LipidXplorer (https://wiki.mpi-cbg.de/lipidx/Main_Page). 
Data files were then imported into the software, using the following settings (Table 2.4), and all 
lipids in the following lipids classes: PA, PC, PE, PI, PS, CL and TAG, were identified with the 
help of Molecular Fragmentation Query Language (MFQL) files. MFQL files were obtained 
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from the LipidXplorer page listed above and aided in the identification of lipids by their m/z 
ratio as well as their fragmentation patterns.  
LipidXplorer’s output data was then opened under a Microsoft Excel file and all detected 
lipids were quantified by comparison with the intensity of the corresponding lipid class’ internal 
standard’s known concentration in the sample. Each quantified lipid had a corresponding internal 
standard from the same lipid class, allowing the calculation of molar percentage of each 
identified lipid species and therefore lipid class.  
 
Table 2.4 Lipid identification by LipidXplorer import settings for data acquired under 
positive and negative mode. (From reference [31])  
 
 Positive Mode Negative Mode 
Selection Window (Da) 
Time Range (sec.) 
Calibration masses 
             MS 
             MS/MS 
m/z range (m/z-m/z) 
             MS 
             MS/MS 
Resolution (FMHW) 
             MS 
             MS/MS 
Tolerance (ppm) 
             MS 
             MS/MS 
Resolution Gradient  (res/(m/z)) 
            MS 
            MS/MS 
Minimum Occupation (0<1) 
             MS 
             MS/MS 
















































Statistical analysis was performed using Microsoft Excel’s (2010) Analysis ToolPack-
VBA. All data are presented as mean ± SEM. The p values were calculated with the help of 
GraphPad t test calculator using an unpaired two-tailed t test.  
 
2.3 Results 
2.3.1 CR alters the intracellular concentrations of cardiolipin, a phospholipid specific for 
mitochondria, in Q and NQ cell populations of chronologically aging yeast 
Cardiolipin (CL) is known to be synthesized only by enzymes confined to the inner 
mitochondrial membrane of the yeast S. cerevisiae [32, 33]. Therefore, in yeast cells this 
phospholipid resides only in mitochondria and is a signature phospholipid of these organelles 
[22]. Using mass spectrometry, I identified and quantitated lipids (including CL) that were 
extracted from purified Q and NQ cell populations of chronologically aging yeast cultured either 
under CR conditions in 0.2% glucose or under non-CR conditions in 2% glucose. I found that the 
CR diet causes the following changes in the cellular concentrations of CL in chronologically 
aging yeast: 1) in chronologically “young” Q cells that have not entered stationary growth phase 
on day 6 of culturing, CR significantly reduces the cellular concentration of CL (Figure 2.1); 2) 
in chronologically “old” Q cells that have entered stationary growth phase, CR enables them to 
maintain the cellular concentration of CL at a substantially higher level than that is seen in yeast 
cultured under non-CR conditions (Figure 2.1); and 3) in chronologically “young” and “old” NQ 
cells, CR significantly increases the cellular concentration of CL (Figure 2.2). 
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Figure 2.1. CR alters the age-related dynamics of changes in CL concentrations within Q cells. 
Cells were cultured in the nutrient-rich YP medium initially containing 0.2% or 2% glucose. Q 
cells were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell 
culturing. Extraction of cellular lipids, as well as their mass spectrometric identification and 
quantitation, were carried out as described in Materials and Methods. Based on these data, the 
concentrations of CL were calculated in mol%. Data are presented as means ± SEM (n = 2; * p < 
0.05). 
 
Figure 2.2. CR alters the age-related dynamics of changes in CL concentrations within NQ cells. 
Cells were cultured in the nutrient-rich YP medium initially containing 0.2% or 2% glucose. NQ 
cells were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell 
culturing. Extraction of cellular lipids, as well as their mass spectrometric identification and 
quantitation, were carried out as described in Materials and Methods. Based on these data, the 
concentrations of CL were calculated in mol%. Data are presented as means ± SEM (n = 2; * p < 
0.05). 
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My findings suggest that the ability of CR to increase cellular concentration of CL, the 
signature lipid of mitochondria, may be responsible in part for the CR-driven longevity extension 
of both Q and NQ cells.  
 
2.3.2 CR reduces the intracellular concentrations of triacylglycerol, a neutral lipid 
specific for lipid droplets, in Q and NQ cell populations of chronologically aging 
yeast 
 
Triacylglycerol (TAG) synthesis takes place in the ER, where it is then packaged into 
highly dynamic neutral lipid storage vesicles known as lipid droplets (LD) [22-24, 34]. LDs 
grow, fragment and shrink (due to lipolysis) and maintain high interactions with protein network 
machines, making them highly integrated into vital processes and defining longevity [34]. TAG’s 
primary location in LDs make it an important lipid to quantify when determining the effect of 
CR and non-CR conditions on LDs in both Q and NQ cells. 
 
Using quantitative mass spectrometry, it was possible to measure TAG concentrations in 
Q and NQ cells of chronologically aging yeast grown under CR or non-CR conditions, to better 
understand the role of TAG, and therefore of LDs, with respect to cellular aging. I found that the 
CR diet significantly decreases TAG concentrations throughout lifespan, both before and after 
cell entry into stationary phase, in both Q and NQ cells (Figures 2.3 and 2.4, respectively). 
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Figure 2.3. CR reduces the concentrations of TAG within Q cells. Cells were cultured in the 
nutrient-rich YP medium initially containing 0.2% or 2% glucose. Q cells were purified from cell 
cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell culturing. Extraction of cellular 
lipids, as well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods. Based on these data, the concentrations of TAG were 
calculated in mol%. Data are presented as means ± SEM (n = 2; * p < 0.05). 
 
 
Figure 2.4. CR decreases the concentration of TAG within NQ cells. Cells were cultured in the 
nutrient-rich YP medium initially containing 0.2% or 2% glucose. NQ cells were purified from 
cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell culturing. Extraction of cellular 
lipids, as well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods. Based on these data, the concentrations of TAG were 




It should be stressed that the entry of Q and NQ cells into stationary growth phase on day 
6 of culturing under CR or non-CR conditions coincides with a dramatic drop in the 
concentration of TAG within these cells (Figures 2.3 and 2.4). My observations suggest that the 
ability of CR to reduce cellular concentration of TAG, a neutral lipid deposited in LDs, may be 
responsible in part for the CR-dependent longevity extension of both Q and NQ cells. 
 
2.3.3 CR alters the intracellular concentrations of phosphatidic acid (PA) in Q and NQ 
cell populations of chronologically aging yeast 
PA is a glycerophospholipid known to be synthesized in the ER [22-24]. After being 
formed in the ER, PA can be used as a precursor for the synthesis of the following lipid classes 
in yeast cells: 1) phosphatidylserine (PS) and phosphatidylinositol (PI) in the ER; 2) TAG in the 
ER; and 3) PG in mitochondria; to be converted to CL in mitochondria [22-24]. PA is 
transported to these organelles from the ER via mitochondria-ER junctions [22-24]. Using 
quantitative mass spectrometry, I found that the CR diet has the following effects on the cellular 
concentrations of PA in chronologically aging yeast: 1) in chronologically “young” Q and NQ 
cells that have not entered stationary growth phase on day 6 of culturing, CR does not alter PA 
concentrations (Figure 2.5); and 2) in chronologically “old” Q and NQ cells that have entered 
stationary growth phase, CR allows these cells to maintain the cellular concentration of PA at a 
significantly higher level than that observed in yeast grown under non-CR conditions (Figure 
2.6). These findings suggest that the CR diet may delay yeast aging by maintaining a higher 
concentration of PA within chronologically “old” Q and/or NQ cells.  
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Figure 2.5. CR increases the concentrations of PA within chronologically “old” Q cells. Cells 
were cultured in the nutrient-rich YP medium initially containing 0.2% or 2% glucose. Q cells 
were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell culturing. 
Extraction of cellular lipids, as well as their mass spectrometric identification and quantitation, 
were carried out as described in Materials and Methods. Based on these data, the concentrations 
of PA were calculated in mol%. Data are presented as means ± SEM (n = 2; * p < 0.05). 
 
 
Figure 2.6. CR increases the concentrations of PA within chronologically “old” NQ cells. Cells 
were cultured in the nutrient-rich YP medium initially containing 0.2% or 2% glucose. NQ cells 
were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell culturing. 
Extraction of cellular lipids, as well as their mass spectrometric identification and quantitation, 
were carried out as described in Materials and Methods. Based on these data, the concentrations 
of PA were calculated in mol%. Data are presented as means ± SEM (n = 2; * p < 0.05). 
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2.3.4 CR alters the intracellular concentrations of PS only in Q cell population and does 
not change PI concentrations in Q and NQ cell populations 
Two glycerophospholipids, PS and PI, are known to be formed directly from PA in the 
ER of yeast cells [22-24]. With the help of quantitative mass spectrometry, I assessed the 
concentrations of these two PA-derived glycerophospholipids in Q and NQ cells purified from 
yeast cultures progressing through the chronological aging process. I discovered that the CR diet 
has the following effects on the cellular concentrations of PS and PI in chronologically aging 
yeast: 1) throughout the chronological lifespan of Q cells, the CR diet enables the cellular 
concentration of PS to be maintained at a substantially higher level than that observed in yeast 
grown under non-CR conditions (Figure 2.7); 2) CR does not alter PS concentrations in NQ cells 
recovered at various stages of chronological aging (Figure 2.8); and 3) CR does not change PI 
concentrations in Q and NQ cell populations of any chronological age (Figures 2.9 and 2.10, 
respectively). My findings suggest that the CR diet may delay aging of Q cells because a 
relatively high concentration of PS is maintained within chronologically “young” and “old” Q 
cells. However, the ability of CR to delay aging of NQ cells is unlikely due to changes in the 
concentration of PS within these cells. Moreover, it seems unlikely that the CR diet delays the 





Figure 2.7. CR increases the concentrations of PS throughout the chronological lifespan of Q 
cells. Cells were cultured in the nutrient-rich YP medium initially containing 0.2% or 2% 
glucose. Q cells were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of 
cell culturing. Extraction of cellular lipids, as well as their mass spectrometric identification and 
quantitation, were carried out as described in Materials and Methods. Based on these data, the 




Figure 2.8. CR does not alter PS concentrations in NQ cells recovered at various stages of 
chronological aging. Cells were cultured in the nutrient-rich YP medium initially containing 
0.2% or 2% glucose. Q cells were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 
18 or 21 of cell culturing. Extraction of cellular lipids, as well as their mass spectrometric 
identification and quantitation, were carried out as described in Materials and Methods. Based on 
these data, the concentrations of PS were calculated in mol%. Data are presented as means ± 




Figure 2.9. CR does not change PI concentrations in Q cells of any chronological age. Cells 
were cultured in the nutrient-rich YP medium initially containing 0.2% or 2% glucose. Q cells 
were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell culturing. 
Extraction of cellular lipids, as well as their mass spectrometric identification and quantitation, 
were carried out as described in Materials and Methods. Based on these data, the concentrations 
of PI were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
 
Figure 2.10. CR does not change PI concentrations in NQ cells of any chronological age. Cells 
were cultured in the nutrient-rich YP medium initially containing 0.2% or 2% glucose. NQ cells 
were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell culturing. 
Extraction of cellular lipids, as well as their mass spectrometric identification and quantitation, 
were carried out as described in Materials and Methods. Based on these data, the concentrations 
of PI were calculated in mol%. Data are presented as means ± SEM (n = 2). 
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2.3.5 CR changes the concentrations of phosphatidylethanolamine (PE) within Q and NQ 
cells and differentially affects the concentrations of phosphatidylcholine (PC) in 
these cell populations  
The glycerophospholipid PE is known to be synthesized from PS in the inner 
mitochondrial membrane [22-24]. After being transported to the ER via mitochondria-ER 
junctions, PE serves as a substrate for the synthesis of PC [22-24]. Using quantitative mass 
spectrometry, I monitored the concentrations of PE and PC in Q and NQ cells purified from 
yeast cultures progressing through the chronological aging process. I found that the CR diet has 
the following effects on the cellular concentrations of these two lipid classes in chronologically 
aging yeast: 1) throughout the chronological lifespan of Q and NQ cells, the cellular 
concentrations of PE are maintained significantly higher in CR cells than that observed non-CR 
cells (Figures 2.11 and 2.12, respectively); 2) CR increases the concentration of PC in Q cells 
recovered at various stages of chronological aging (Figure 2.13); 3) in chronologically “young” 
NQ cells that have not entered stationary growth phase on day 6 of culturing, CR increases the 
concentration of PC (Figure 2.14); and 4) in chronologically “old” NQ cells that have entered 
stationary growth phase, CR does not alter PC concentrations (Figure 2.14). My findings suggest 
that the CR diet may delay aging of Q cells by enabling the maintenance of high concentrations 
of PE and PC at all stages of chronological aging. Moreover, my observations suggest that the 
CR diet may delay aging of NQ cells by maintaining high concentration of PE within 
chronologically “young” and “old” NQ cells and/or by increasing PC concentrations within 




Figure 2.11. CR increases the concentrations of PE throughout the chronological lifespan of Q 
cells. Cells were cultured in the nutrient-rich YP medium initially containing 0.2% or 2% 
glucose. Q cells were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of 
cell culturing. Extraction of cellular lipids, as well as their mass spectrometric identification and 
quantitation, were carried out as described in Materials and Methods. Based on these data, the 




Figure 2.12. CR increases the concentrations of PE in NQ cells recovered at various stages of 
chronological aging. Cells were cultured in the nutrient-rich YP medium initially containing 
0.2% or 2% glucose. NQ cells were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 
14, 18 or 21 of cell culturing. Extraction of cellular lipids, as well as their mass spectrometric 
identification and quantitation, were carried out as described in Materials and Methods. Based on 
these data, the concentrations of PE were calculated in mol%. Data are presented as means ± 




Figure 2.13. CR increases the concentrations of PC throughout the chronological lifespan of Q 
cells. Cells were cultured in the nutrient-rich YP medium initially containing 0.2% or 2% 
glucose. Q cells were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of 
cell culturing. Extraction of cellular lipids, as well as their mass spectrometric identification and 
quantitation, were carried out as described in Materials and Methods. Based on these data, the 




Figure 2.14. In chronologically “young” NQ cells that have not entered stationary growth phase, 
CR increases the concentration of PC, whereas in chronologically “old” NQ cells that have 
entered stationary growth phase, this dietary regimen does not alter PC concentrations. Cells 
were cultured in the nutrient-rich YP medium initially containing 0.2% or 2% glucose. NQ cells 
were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell culturing. 
Extraction of cellular lipids, as well as their mass spectrometric identification and quantitation, 
were carried out as described in Materials and Methods. Based on these data, the concentrations 
of PC were calculated in mol%. Data are presented as means ± SEM (n = 2; * p < 0.05). 
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2.4 Discussion 
Studies described in this chapter of my thesis have demonstrated that the CR diet alters 
the concentrations of various classes of lipids within Q and NQ cells of chronologically aging 
yeast. These studies strongly support the notion that this longevity-extending dietary intervention 
causes a substantial remodeling of lipid metabolism and transport within both Q and NQ cells. 
Based on observations presented in this chapter, I propose a hypothetical model on how CR may 
delay yeast chronological aging by altering the age-related dynamics of various lipids in Q and 
NQ cells. Using the centrifugation-based approach for separating Q and NQ cell populations, I 
found that yeast cells cultured under CR in 0.2% glucose enter differentiation program leading to 
formation of ″heavy″ (high-density) Q and ″light″ (low-density) NQ cell subpopulations during 
the logarithmic (L) growth phase (Figure 2.15) - i.e. much earlier than yeast cells cultured under 
non-CR conditions in 2% glucose and known to differentiate only when they reach stationary 
(ST) growth phase (Figure 2.15) [4, 5, 15-18]. As other graduate students in the Titorenko 
laboratory have demonstrated, there are two differentiation programs that in chronologically 
aging yeast link cellular aging to cell cycle regulation, preservation of a Q state, and entry into 
and advancement through an NQ state (Feldman et al., manuscript in preparation). The 
differentiation program 1 and the maintenance program 1 function in yeast cultured under CR 
conditions, whereas the differentiation program 2 and the maintenance program 2 operate in 
yeast grown under non-CR conditions (Figure 2.16). The two differentiation programs and the 
two maintenance program define longevity of chronologically aging yeast by setting up the 
following: 1) a growth phase in which G1 cell cycle arrest occurs, 2) the efficacy with which a 
stem cell  
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Figure 2.15. Yeast cells grown under CR in 0.2% glucose enter differentiation program leading 
to formation of ″heavy″ (high-density) Q and ″light″ (low-density) NQ cell subpopulations when 
a yeast culture reaches L growth phase. Yeast cells were cultured in the complete (nutrient-rich) 
YEP medium initially containing 0.2% glucose (CR conditions) or 2% glucose (non-CR 
conditions), recovered from logarithmic (L), diauxic (D), post-diauxic (PD) or stationary (ST) 
growth phase and subjected to centrifugation in Percoll density gradient as described in 
″Materials and Methods″. 
 
 
Figure 2.16. A model of two differentiation programs and two maintenance programs that in 
chronologically aging yeast link cellular aging to cell cycle regulation, preservation of a Q state, 
and entry into and advancement through an NQ state. See text for more details. Abbreviations: 
CR, caloric restriction; L, logarithmic; nDNA, nuclear DNA; NL, nutrient limitation; mDNA, 
mitochondrial DNA; ST, stationary. 
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niche of heavy Q cells (GqH) is maintained and depleted by converting to heavy NQ cells (GnqH) 
in an age-related manner, 3) the age-related rate with which heavy Q cells progress through 
apoptotic and necrosis-like subroutines of programmed death, 4) the age-related rate with which 
heavy Q cells are converted to light Q cells (GqL), 5) the age-related rate with which light Q cells 
differentiate into light NQ cells (GnqL), and 6) the age-related rate with which light NQ cells 
advance through apoptotic and necrosis-like forms of programmed death (Figure 2.16) (Feldman 
et al., manuscript in preparation). 
My hypothetical model on how CR may delay yeast chronological aging by altering the 
age-related dynamics of various lipids in different organelles of Q and NQ cells posits the 
following: 1) in “young” Q cells, CR reduces the concentration of TAG and CL, possibly by 
decelerating their synthesis in the ER and mitochondria, respectively (Figure 2.17); 2) in 
“young” Q cells, CR increases the concentrations of PS, PE, and PC, perhaps by stimulating their 
synthesis and interorganellar transport in the ER and mitochondria (Figure 2.17); 3) in “old” Q 
cells, CR reduces the concentration of TAG, probably by decelerating the synthesis of this 
neutral lipid in the ER (Figure 2.18);  4) in “old” Q cells, CR increases the concentrations of PA, 
PS, PE, PC and CL, perhaps by stimulating their synthesis and interorganellar transport within 
the ER and mitochondria (Figure 2.18); 5) in “young” NQ cells, CR reduces the concentration of 
TAG, possibly by decelerating its synthesis in the ER (Figure 2.19); 6) in “young” NQ cells, CR 
increases the concentrations of PE, PC and CL, likely by stimulating their synthesis and 
interorganellar transport within the ER and mitochondria (Figure 2.19); 7) in “old” NQ cells, CR 
reduces the concentration of TAG, probably by decelerating the synthesis of this neutral lipid in 
the ER (Figure 2.20); and 8) in “old” NQ cells, CR increases the concentrations of PA, PE and 
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CL, perhaps by stimulating their synthesis and interorganellar transport within the ER and 
mitochondria (Figure 2.20).         
 
Figure 2.17. A hypothetical model on how CR alters the metabolism and interorganellar 
transport of some lipids in “young” Q cells. The model is based on mass spectrometric 
lipidomics of purified Q cells that were recovered from yeast cultures prior to entry into 
stationary growth phase. From the data of lipidomic analysis, I inferred an outline of the rates 
and efficiencies of lipid synthesis and transport that were increased (thick solid arrows) or 
decreased (thin dashed arrows) under CR conditions. Arrows next to the names of lipid classes 
denote those of them whose concentrations are elevated (red arrows) or reduced (blue arrows) by 
CR. 
 
Figure 2.18. A hypothetical model on how CR alters the metabolism and interorganellar 
transport of some lipids in “old” Q cells. The model is based on mass spectrometric lipidomics of 
purified Q cells that were recovered from yeast cultures after entry into stationary growth phase. 
From the data of lipidomic analysis, I inferred an outline of the rates and efficiencies of lipid 
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synthesis and transport that were increased (thick solid arrows) or decreased (thin dashed arrows) 
under CR conditions. Arrows next to the names of lipid classes denote those of them whose 
concentrations are elevated (red arrows) or reduced (blue arrows) by CR. 
 
 
Figure 2.19. A hypothetical model on how CR alters the metabolism and interorganellar 
transport of some lipids in “young” NQ cells. The model is based on mass spectrometric 
lipidomics of purified NQ cells that were recovered from yeast cultures prior to entry into 
stationary growth phase. From the data of lipidomic analysis, I inferred an outline of the rates 
and efficiencies of lipid synthesis and transport that were increased (thick solid arrows) or 
decreased (thin dashed arrows) under CR conditions. Arrows next to the names of lipid classes 
denote those of them whose concentrations are elevated (red arrows) or reduced (blue arrows) by 
CR. 
 
Figure 2.20. A hypothetical model on how CR alters the metabolism and interorganellar 
transport of some lipids in “old” NQ cells. The model is based on mass spectrometric lipidomics 
of purified NQ cells that were recovered from yeast cultures after entry into stationary growth 
phase. From the data of lipidomic analysis, I inferred an outline of the rates and efficiencies of 
lipid synthesis and transport that were increased (thick solid arrows) or decreased (thin dashed 
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arrows) under CR conditions. Arrows next to the names of lipid classes denote those of them 
whose concentrations are elevated (red arrows) or reduced (blue arrows) by CR. 
 
 
It remains to be determined which of the alterations in lipid concentrations observed in Q 
and NQ cells are essential for the ability of CR to delay aging of these cell populations; it is 
possible that some of these alterations just coincide with the progress of chronological aging. To 
address this key aspect of the proposed model, it will be important in the future to assess how 
single-gene mutations eliminating enzymes that accelerate individual reactions of lipid 
metabolism in yeast (Figures 2.17 – 2.20) influence the efficiency with which CR slows down 
yeast chronological aging. Moreover, a challenge remains to understand how the alterations of 
lipid concentrations seen in chronologically aging Q and NQ cells delay their aging. It is 
conceivable that, by redirecting the flow of fatty acids from the synthesis of TAG to the 
formation of glycerophospholipids in the ER and mitochondria, the CR diet increases the 
efficiencies with which these two organelles support some pro-longevity cellular processes. 
These longevity-assuring processes may include mitochondrial respiration and ATP synthesis, 
unfolded protein response in mitochondrial and ER, and/or the modulation of intracellular ROS 
by oxidative enzymes residing in these organelles.                   
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3 Lithocholic acid, a longevity-extending natural chemical compound, changes lipid 
compositions of quiescent and non-quiescent cells of chronologically aging yeast 
 
3.1 Abstract 
 Lithocholic acid (LCA), the most hydrophobic bile acid, has been shown to extend 
longevity of chronologically aging yeast mainly under CR conditions [15, 26 - 30]. In studies 
described in this Chapter of my thesis, I used centrifugation in Percoll density gradient to 
separate quiescent (Q) and non-quiescent (NQ) cells of chronologically aging yeast. The Q and 
NQ populations of cells were purified from yeast cultured either under CR conditions in 0.2% 
glucose with or without LCA. Using quantitative mass spectrometry, I assessed how LCA 
influences age-related changes in the lipid composition of purified populations of Q and NQ 
yeast grown under CR conditions. My findings imply LCA causes a remodeling of lipid 
metabolism and transport in both Q and NQ cells limited in calorie supply. Based on these 
findings, I propose a working hypothesis on how this bile acid delays chronological aging of 
yeast cells by altering lipid dynamics within different cellular organelles.      
 
3.2 Materials and Methods 
Yeast strains, media and growth conditions 
The wild-type strain Saccharomyces cerevisiae BY4742 (MATα his3∆1 leu2∆0 lys2∆0 
ura3∆0) from Thermo Scientific/Open Biosystems was grown in YEP medium (1% yeast 
extract, 2% peptone; both from Fisher Scientific; #BP1422-2 and #BP1420-2, respectively) 
initially containing 0.2% or 2% glucose (#D16-10; Fisher Scientific) as carbon source. Cells 
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were cultured at 30oC with rotational shaking at 200 rpm in Erlenmeyer flasks at a “flask 
volume/medium volume” ratio of 5:1. 
 
Pharmacological manipulation of chronological lifespan 
Chronological lifespan analysis was performed as described above in this section. The 
lithocholic (LCA) (#L6250) bile acid was from Sigma. The stock solution of LCA in water was 
made on the day of adding this compound to cell cultures. LCA was added to growth medium in 
water at the final concentration of 50 µM immediately following cell inoculation into the 
medium.  
Separation of Q and NQ cells by centrifugation in Percoll density gradient 
1 mL of 1.5 M NaCl (#S7653; Sigma) was placed into a 50-mL Falcon tube, and 8 mL of 
the Percoll solution (#P1644; Sigma) was added to this tube. The NaCl and Percoll solution was 
then mixed by pipetting. To form two Percoll density gradients, 4 mL of the NaCl/Percoll 
mixture was put into each of the two polyallomer tubes for an MLS-50 rotor for an Optima MAX 
ultracentrifuge (all from Beckman Coulter). The tubes were centrifuged at 25,000 × g (16,000 
rpm) for 15 min at 4oC in an Optima MAX ultracentrifuge. A sample of yeast cells were taken 
from a culture at a certain time point. A fraction of the sample was diluted in order to determine 
the total number of cells per mL of culture using a hemacytometer (#0267110; Fisher Scientific). 
For each Percoll density gradient, 1  109 yeast cells were placed into a 15-mL Falcon tube and 
pelleted by centrifugation at 5,000 rpm for 7 min at room temperature in a Centra CL2 clinical 
centrifuge (Thermo IEC). Pelleted cells were resuspended in 500 μL of 50 mM Tris/HCl buffer 
(pH 7.5), overlaid onto the preformed gradient with a syringe and needle to avoid disrupting the 
gradient, and centrifuged at 2,300 × g (5,000 rpm) for 30 min at 25oC in an Optima MAX 
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ultracentrifuge. The upper and lower fractions of cells were removed with a micropipette, 
discarding the gradient with no visible band of cells and Percoll was removed by washing cells 
twice with 50 mM Tris/HCl buffer (pH 7.5) and cells were resuspended in 1 mL of 50 mM 
Tris/HCl buffer (pH 7.5) for cell counts and preparation for freezing of the cell pellet.  
 
Cell number measurement of Q and NQ cells separated by centrifugation in Percoll density 
gradient and preparation of pellet for storage until lipid extraction 
A 50 µL aliquot of the upper or lower fraction of cells recovered and washed from the 
Percoll gradient were diluted in order to determine the total number of cells per fraction using a 
hemacytometer (#0267110; Fisher Scientific). 10 µL of serial dilutions (1:10 to 1:103) of cells 
were applied to the hemacytometer, where each large square is calibrated to hold 0.1 µL. The 
number of cells in 4 large squares was then counted and an average was taken in order to ensure 
greater accuracy. The concentration of cells was calculated as follows: number of cells per large 
square  dilution factor × 10 × 1,000 = total number of cells per mL of fraction. The remaining 
950 µL of the cell aliquots were washed twice with 155 mM ammonium bicarbonate (pH 8.0) in 
preparation for the freezing of the cell pellet at -80ᴼC until the lipid extraction.  
 
Lipid extraction from purified populations of Q and NQ cells 
The lipid extraction of purified populations of quiescent and non-quiescent cells used 
Richard et al.’s modified version of Bligh and Dyer’s lipid purification and extraction protocol 
[31]. The pelleted cell fractions kept at -80ᴼC were thawed on ice before being resuspended in 
1mL of cold nanopure water. The volume that contained 5 × 107 cells of each fraction was 
transferred to the appropriate 15-mL high-strength glass screw top centrifuge tube with a Teflon 
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lined cap (#0556912; Fisher Scientific). The volume of each sample was topped off to 1 mL with 
cold nanopure water. To each tube the following was added: 20 µL of the internal standard mix 
prepared in Chromasolv HPLC (>99.9%) chloroform (Sigma-Aldrich) (Table 3.1), 800 uL of 
425-600 µM acid-washed glass beads to break open the cells (#G8772; Sigma-Aldrich) and 3 
mL of a Chromasolv HPLC (>99.9%) chloroform: methanol mixture (both from Sigma-Aldrich) 
at a 17:1 ratio. The samples were then vortexed vigorously for 2 hours at 4ᴼC. At room 
temperature, the samples were then centrifuged in a Centra CL2 clinical centrifuge for 5 minutes 
separating the upper aqueous and lower organic phase which contained nonpolar lipids TAG, 
PC, PE and PG. The lower organic layer was transferred to another labelled 15 mL glass high-
strength centrifuge tube using a glass Pasteur pipette with careful attention not to disrupt the 
glass beads or upper aqueous phase. 1.5 mL of 2:1 chloroform: methanol solution was added to 
the remaining upper aqueous phase allowing the separation of polar lipids PA, PS, PI and CL. 
The samples were again vortexed vigorously at 4ᴼC for 1 hour. The non-polar organic band was 
kept at 4ᴼC for the duration of the second vortexing. At the end of 1 hour, the samples were 
again centrifuged for 5 minutes at 3,000 rpm and the lower organic phase was separated and 
added to the corresponding non-polar organic phase with a glass Pasteur pipette. With both lower 
organic phases combined, the solvent was evaporated off by nitrogen gas flow. Once all solvent 
was evaporated, the remaining lipid film was dissolved and resuspended in 100 µL of 1:2 
chloroform: methanol and immediately transferred into 2 mL glass vials with Teflon screw tops 
to avoid evaporation until samples were analysed by mass spectrometry. Samples were then 





Table 3.1: Internal standard mix composition (modified from reference [31]) 
 
Internal Standards CL, PA, PE, PG, PS and PC are all from Avanti Polar Lipid, Alabaster, AL, 
USA. TAG Internal standard originates from Larodan, Malmo, Sweden. 
 
Lipid identification and quantitation of Q and NQ cells using mass spectrometry 
Samples were diluted 1:1 with 1:2 chloroform: methanol and 0.1% ammonium hydroxide 
for improved ionization efficiency. Samples were injected one at a time using a Thermo Orbitrap 
Velos Mass Spectrometer equipped with HESI-II ion source (Thermo Scientific) at a flow rate of 
5 µL/ minute. The instrument settings for the Orbitrap used the optimized settings listed in 
Richard’s et al.’s tune file (Table 3.2).  
 
Table 3.2: Thermo Orbitrap Velos mass spectrometer’s tune file instrument settings (from 
reference [31]) 
 
Instrument polarity Positive Negative 
Source voltage (kV) 3.9 4 
Capillary temperature (ᴼC) 275 275 
Sheath gas flow 5 5 
Aux gas flow 1 1 
FT-MS injection time (ms) 100 500 










number double bonds 
on fatty acid chain) 








in mix                    
(mg/µL) 
Negative 
CL 14:0 / 14:0 / 14:0 /14:0 1274.9000 619.4157 0.10 
FFA 19:0 298.2872 297.2711 0.02 
PA 14:0 / 14:0 614.3920 591.4026 0.10 
PE 14:0 / 14:0 635.4526 634.4448 0.10 
PG 14:0 / 14:0 688.4290 665.4394 0.10 
PS 14:0 / 14:0 701.4240 678.4271 0.02 
Positive TAG 13:0 / 13:0 / 13:0 680.5955 698.6299 0.10 PC 13:0 / 13:0 649.4683 650.4761 0.10 
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Data was acquired according to the Instrument Method for data-dependent acquisition for 
5 minutes in both positive and negative mode by the FTMS analyser at a resolution of 100,000 
for both MS and MS/MS data (Table 3.3). 
 
Table 3.3: Instrument method for data-dependent acquisition (from reference [31]) 
 
Acquisition time                                  5 minutes ( with a 0.25 minute delay) 
Instrument polarity Positive Negative 




















































Between each sample, the line was flushed with 1:2 chloroform: methanol until the 
background ion detection steadied and returned back into the baseline level. Diluted internal 
standard mix was injected multiple times throughout the acquisition to ensure no sensitivity loss 
throughout the run. 
Once all data was acquired, raw files were converted to open mzXML format using 
ProteoWizard MSConvert software (http://proteowizard.sourceforge.net/), the file format used 
by the Lipid Identification Software LipidXplorer (https://wiki.mpi-cbg.de/lipidx/Main_Page). 
Data files were then imported into the software, using the following settings (Table 3.4), and all 
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lipids in the following lipids classes: PA, PC, PE, PI, PS, CL and TAG, were identified with the 
help of Molecular Fragmentation Query Language (MFQL) files. MFQL files were obtained 
from the LipidXplorer page listed above and aided in the identification of lipids by their m/z 
ratio as well as their fragmentation patterns.  
LipidXplorer’s output data was then opened under a Microsoft Excel file and all detected 
lipids were quantified by comparison with the intensity of the corresponding lipid class’ internal 
standard’s known concentration in the sample. Each quantified lipid had a corresponding internal 
standard from the same lipid class, allowing the calculation of molar percentage of each 
identified lipid species and therefore lipid class.  
 
Table 3.4 Lipid identification by LipidXplorer import settings for data acquired under 
positive and negative mode. (From reference [31])  
 
 Positive Mode Negative Mode 
Selection Window (Da) 
Time Range (sec.) 
Calibration masses 
             MS 
             MS/MS 
m/z range (m/z-m/z) 
             MS 
             MS/MS 
Resolution (FMHW) 
             MS 
             MS/MS 
Tolerance (ppm) 
             MS 
             MS/MS 
Resolution Gradient  (res/(m/z)) 
            MS 
            MS/MS 
Minimum Occupation (0<1) 
             MS 
             MS/MS 














































Statistical analysis was performed using Microsoft Excel’s (2010) Analysis ToolPack-
VBA. All data are presented as mean ± SEM. The p values were calculated with the help of 
GraphPad t test calculator using an unpaired two-tailed t test.  
 
3.3 Results 
3.3.1 LCA does not alter the intracellular concentrations of CL, a phospholipid specific 
for mitochondria, in Q and NQ cell populations of chronologically aging yeast 
grown under CR conditions 
Using quantitative mass spectrometry, I monitored the concentrations of CL in Q and NQ 
cells of chronologically aging yeast grown under CR conditions in 0.2% glucose. I found that 
LCA does not change CL concentrations in Q and NQ cell populations of any chronological age 
(Figures 3.1 and 3.2, respectively). My findings suggest that LCA delays aging of Q and NQ 
cells under CR conditions not by altering the concentration of CL, the signature lipid of 





Figure 3.1. LCA does not alter the age-related dynamics of changes in CL concentrations within 
Q cells under CR conditions. Cells were cultured in the nutrient-rich YP medium initially 
containing 0.2% glucose with or without LCA. Q cells were purified from cell cultures recovered 
on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell culturing. Extraction of cellular lipids, as well as their 
mass spectrometric identification and quantitation, were carried out as described in Materials and 
Methods. Based on these data, the concentrations of CL were calculated in mol%. Data are 




Figure 3.2. LCA does not change the concentrations CL within NQ cells grown under CR 
conditions. Cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose 
with or without LCA. NQ cells were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 
14, 18 or 21 of cell culturing. Extraction of cellular lipids, as well as their mass spectrometric 
identification and quantitation, were carried out as described in Materials and Methods. Based on 
these data, the concentrations of CL were calculated in mol%. Data are presented as means ± 
SEM (n = 2). 
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3.3.2 LCA alters the intracellular concentrations of TAG, a neutral lipid specific for LD, 
in Q and NQ cell populations of chronologically aging yeast grown under CR 
conditions 
With the help of quantitative mass spectrometry, I assessed how LCA impacts the 
concentrations of TAG in Q and NQ cells of chronologically aging yeast grown under CR 
conditions and recovered at various stages of the aging process. I found that LCA has the 
following effects on the cellular concentrations of TAG in yeast limited in calorie supply: 1) in 
chronologically “young” (cultured from 1 to 6 days) and “middle-aged” (cultured from 8 to 11 
days) Q cells but not in “old” Q cells cultured for 14 days and longer, LCA increases the 
concentration of TAG (Figure 3.3); and 2) only in chronologically “middle-aged” (cultured from 
8 to 11 days) NQ cells but not in “young” (cultured from 1 to 6 days) or “old” (cultured for 14 
days and longer) NQ cells, LCA significantly increased the concentration of TAG (Figure 3.4). 
These findings suggest that LCA may delay aging of Q cells under CR conditions by enabling 
these cells to maintain relatively high concentrations of TAG within chronologically “young” 
and “middle-aged” Q cells. Furthermore, it is conceivable that the ability of LCA to delay aging 
of NQ cells under CR conditions may be due to its ability to increase the concentration of TAG 
in “middle-aged” NQ cells. 
 
 3.3.3 LCA alters the concentrations of PA only in Q cells of chronologically aging yeast 
grown under CR conditions 
Using quantitative mass spectrometry, I monitored the age-related dynamics of changes 
in the concentrations of PA in Q and NQ cell populations of chronologically aging yeast  
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Figure 3.3. LCA increases the concentration of TAG in chronologically “young” (cultured from 
1 to 6 days) and “middle-aged” (cultured from 8 to 11 days) Q cells but not in “old” Q cells 
cultured for 14 days and longer. Cells were cultured in YP medium initially containing 0.2% 
glucose with or without LCA. Q cells were purified from cell cultures recovered on days 1, 4, 6, 
8, 11, 14, 18 or 21 of culturing. Extraction of cellular lipids, as well as their mass spectrometric 
identification and quantitation, were carried out as described in Materials and Methods. Based on 
these data, the concentrations of TAG were calculated in mol%. Data are presented as means ± 
SEM (n = 2; * p < 0.05). 
 
Figure 3.4. LCA increases the concentration of TAG only in chronologically “middle-aged” 
(cultured from 8 to 11 days) NQ cells but not in “young” (cultured from 1 to 6 days) or “old” 
(cultured for 14 days and longer) NQ cells. Cells were cultured in YP medium initially 
containing 0.2% glucose with or without LCA. NQ cells were purified from cell cultures 
recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of culturing. Extraction of cellular lipids, as well as 
their mass spectrometric identification and quantitation, were carried out as described in 
Materials and Methods. Based on these data, the concentrations of TAG were calculated in 
mol%. Data are presented as means ± SEM (n = 2; * p < 0.05). 
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grown under CR conditions in the presence or absence of LCA. I discovered that LCA has the 
following effects on the cellular concentrations of PA in yeast limited in calorie supply: 1) in 
chronologically “young” (cultured from 1 to 6 days) and “middle-aged” (cultured from 8 to 11 
days) Q cells, but not in “old” Q cells, cultured for 14 days and longer, LCA decreases the 
concentration of PA (Figure 3.5); and 2) LCA does not change PA concentrations in NQ cells of 
any chronological age (Figure 3.6). My findings suggest that the ability of LCA to delay 
chronological aging of yeast limited in calorie supply may be due to the ability of this bile acid to 
decrease the concentration of PA within chronologically “young” and “middle-aged” Q cells. My 
findings also imply that LCA does not alter the concentration of PA within NQ cells when 
delaying aging of NQ cells under CR conditions.  
 
Figure 3.5. LCA decreases the concentration of PA in chronologically “young” (cultured from 1 
to 6 days) and “middle-aged” (cultured from 8 to 11 days) Q cells but not in “old” Q cells 
cultured for 14 days and longer. Cells were cultured in YP medium initially containing 0.2% 
glucose with or without LCA. Q cells were purified from cell cultures recovered on days 1, 4, 6, 
8, 11, 14, 18 or 21 of culturing. Extraction of cellular lipids, as well as their mass spectrometric 
identification and quantitation, were carried out as described in Materials and Methods. Based on 
these data, the concentrations of PA were calculated in mol%. Data are presented as means ± 





Figure 3.6. LCA does not change PA concentrations in NQ cells of any chronological age. Cells 
were cultured in YP medium initially containing 0.2% glucose with or without LCA. NQ cells 
were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of culturing. 
Extraction of cellular lipids, as well as their mass spectrometric identification and quantitation, 
were carried out as described in Materials and Methods. Based on these data, the concentrations 
of PA were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
3.3.4 LCA alters the concentrations of PI only in “old” Q cells and does not change PS 
concentrations in Q and NQ cells of chronologically aging yeast grown under CR 
conditions 
With the help of quantitative mass spectrometry, I assessed how LCA impacts the 
concentrations of PS and PI in Q and NQ cells of chronologically aging yeast cultured under CR 
conditions. I found that LCA does not change PS concentrations in Q or NQ cells of any 
chronological age (Figures 3.7 and 3.8, respectively). Moreover, I discovered that LCA has the 
following effects on the cellular concentrations of PI in yeast limited in calorie supply: 1) in 
chronologically “middle-aged” (cultured from 11 to 14 days) and “old” (cultured for 14 days and 
longer) Q cells but not in chronologically “young” (cultured from 1 to 8 days) Q cells, LCA 
increases the concentration of PI  
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Figure 3.7. LCA does not change PS concentrations in Q cells of any chronological age. Cells 
were cultured in YP medium initially containing 0.2% glucose with or without LCA. Q cells 
were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of culturing. 
Extraction of cellular lipids, as well as their mass spectrometric identification and quantitation, 
were carried out as described in Materials and Methods. Based on these data, the concentrations 
of PS were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
 
Figure 3.8. LCA does not change PS concentrations in NQ cells of any chronological age. Cells 
were cultured in YP medium initially containing 0.2% glucose with or without LCA. NQ cells 
were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of culturing. 
Extraction of cellular lipids, as well as their mass spectrometric identification and quantitation, 
were carried out as described in Materials and Methods. Based on these data, the concentrations 
of PS were calculated in mol%. Data are presented as means ± SEM (n = 2). 
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Figure 3.9. LCA increases the concentration of PI in chronologically “middle-aged” (cultured 
from 11 to 14 days) and “old” (cultured for 14 days and longer) Q cells but not in 
chronologically “young” (cultured from 1 to 8 days) Q cells. Cells were cultured in YP medium 
initially containing 0.2% glucose with or without LCA. Q cells were purified from cell cultures 
recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of culturing. Extraction of cellular lipids, as well as 
their mass spectrometric identification and quantitation, were carried out as described in 
Materials and Methods. Based on these data, the concentrations of PI were calculated in mol%. 
Data are presented as means ± SEM (n = 2; * p < 0.05). 
 
 
Figure 3.10. LCA does not change PI concentrations in NQ cells of any chronological age. Cells 
were cultured in YP medium initially containing 0.2% glucose with or without LCA. NQ cells 
were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of culturing. 
Extraction of cellular lipids, as well as their mass spectrometric identification and quantitation, 
were carried out as described in Materials and Methods. Based on these data, the concentrations 
of PI were calculated in mol%. Data are presented as means ± SEM (n = 2). 
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(Figure 3.9); and 2) LCA does not change PI concentrations in NQ cells of any chronological 
age (Figure 3.10). These observations suggest that LCA delays aging of Q and NQ cells limited 
in calorie supply not by altering the concentrations of PS in these cells. Furthermore, the ability 
of LCA to delay aging of NQ cells under CR conditions is unlikely to be caused by any changes 
in concentration of PI in these cells. Moreover, it seems that LCA may delay aging of Q cells 
limited in calorie supply by increasing the concentration of PI in chronologically “middle-aged” 
(cultured from 11 to 14 days) and “old” (cultured for 14 days and longer) Q cells but not in 
chronologically “young” (cultured from 1 to 8 days) Q cells. 
 
3.3.5 LCA does not change the concentrations of PE and PC within Q and NQ cells of 
chronologically aging yeast grown under CR conditions 
Using quantitative mass spectrometry, I monitored the concentrations of PE and PC in Q 
and NQ cells purified from chronologically aging yeast cultured under CR conditions. I 
discovered that LCA does not alter PE and PC concentrations in Q and NQ cells of any 
chronological age (Figures 3.11, 3.12, 3.13 and 3.14, respectively). These findings imply that 
LCA delays aging of Q and NQ cells limited in calorie supply by a mechanism that does not alter 






Figure 3.11. LCA does not change PE concentrations in Q cells of any chronological age. Cells 
were cultured in YP medium initially containing 0.2% glucose with or without LCA. Q cells 
were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of culturing. 
Extraction of cellular lipids, as well as their mass spectrometric identification and quantitation, 
were carried out as described in Materials and Methods. Based on these data, the concentrations 





Figure 3.12. LCA does not change PE concentrations in NQ cells of any chronological age. 
Cells were cultured in YP medium initially containing 0.2% glucose with or without LCA. NQ 
cells were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of culturing. 
Extraction of cellular lipids, as well as their mass spectrometric identification and quantitation, 
were carried out as described in Materials and Methods. Based on these data, the concentrations 




Figure 3.13. LCA does not change PC concentrations in Q cells of any chronological age. Cells 
were cultured in YP medium initially containing 0.2% glucose with or without LCA. Q cells 
were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of culturing. 
Extraction of cellular lipids, as well as their mass spectrometric identification and quantitation, 
were carried out as described in Materials and Methods. Based on these data, the concentrations 




Figure 3.14. LCA does not change PC concentrations in NQ cells of any chronological age. 
Cells were cultured in YP medium initially containing 0.2% glucose with or without LCA. Q 
cells were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of culturing. 
Extraction of cellular lipids, as well as their mass spectrometric identification and quantitation, 
were carried out as described in Materials and Methods. Based on these data, the concentrations 





Studies described in this chapter of my thesis have demonstrated that in yeast limited in 
calorie supply LCA causes a remodeling of lipid metabolism and transport within both Q and 
NQ cells. My findings imply that the LCA-driven remodeling of lipid dynamics in each of these 
cell populations differs substantially from the one observed in Q and NQ cells subjected to CR in 
the absence of LCA. Based on observations presented in this chapter, I propose a hypothetical 
model on how LCA, a longevity-extending natural chemical compound, may delay yeast 
chronological aging by altering the age-related dynamics of various lipids in Q and NQ cells 
progressing through consecutive stages of the aging process. My model posits the following: 1) 
in “young” Q cells, LCA increases the concentration of TAG, perhaps by intensifying its 
synthesis from PA and/or CoA-esters of free fatty acids in the ER (Figure 3.15); 2) in “young” Q 
cells, LCA reduces the concentration of PA, probably by decelerating the synthesis of this 
glycerophospholipid and/or accelerating its incorporation into TAG in the ER (Figure 3.15); 3) 
in “middle-aged” Q cells, LCA elevates the concentrations of TAG and PI, likely by stimulating 
their synthesis in the ER (Figure 3.16); 4) in “middle-aged” Q cells, LCA decreases the 
concentration of PA, perhaps by slowing down its synthesis and/or speeding up its incorporation 
into TAG in the ER (Figure 3.16); 5) in “old” Q cells, LCA increases the concentration of PI, 
possibly by stimulating its formation in the ER (Figure 3.17); 6) in “young” NQ cells, LCA does 
not alter the concentrations of lipids (Figure 3.18); 7) in “middle-aged” NQ cells, LCA increases 
the concentration of TAG, probably by activating its synthesis from CoA-esters of free fatty 
acids in the ER (Figure 3.19); and 8) in “old” NQ cells, LCA does not change the concentrations 
of lipids (Figure 3.20). 
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Figure 3.15. A hypothetical model on how LCA alters the metabolism of TAG and PA in 
“young” Q cells. The model is based on mass spectrometric lipidomics of purified Q cells that 
were recovered from yeast cultured from 1 to 6 days prior to entry into stationary growth phase 
under CR conditions in 0.2% glucose. From the data of lipidomic analysis, I inferred an outline 
of the rates and efficiencies of lipid metabolism that were increased (thick solid arrows) or 
decreased (thin dashed arrows) by LCA under CR conditions. Arrows next to the names of lipid 
classes denote those of them whose concentrations are elevated (red arrows) or reduced (blue 





Figure 3.16. A hypothetical model on how LCA alters the metabolism of TAG, PA and PI in 
“middle-aged” Q cells. The model is based on mass spectrometric lipidomics of purified Q cells 
that were recovered from yeast cultured from 8 to 11 days under CR conditions in 0.2% glucose. 
From the data of lipidomic analysis, I inferred an outline of the rates and efficiencies of lipid 
metabolism that were increased (thick solid arrows) or decreased (thin dashed arrows) by LCA 
under CR conditions. Arrows next to the names of lipid classes denote those of them whose 




Figure 3.17. A hypothetical model on how LCA alters the metabolism of PI in “old” Q cells. 
The model is based on mass spectrometric lipidomics of purified Q cells that were recovered 
from yeast cultured for 14 days and longer under CR conditions in 0.2% glucose. From the data 
of lipidomic analysis, I inferred an outline of the rates and efficiencies of lipid metabolism that 
were increased (thick solid arrows) by LCA under CR conditions. A red arrow next to the name 





Figure 3.18. A hypothetical model on how LCA influences lipid metabolism in “young” NQ 
cells. The model is based on mass spectrometric lipidomics of purified NQ cells that were 
recovered from yeast cultured from 1 to 6 days prior to entry into stationary growth phase under 
CR conditions in 0.2% glucose. From the data of lipidomic analysis, I inferred that LCA does not 





Figure 3.19. A hypothetical model on how LCA alters the metabolism of TAG in “middle-aged” 
NQ cells. The model is based on mass spectrometric lipidomics of purified NQ cells that were 
recovered from yeast cultured from 8 to 11 days under CR conditions in 0.2% glucose. From the 
data of lipidomic analysis, I inferred an outline of the rates and efficiencies of lipid metabolism 
that were increased (thick solid arrows) by LCA under CR conditions. Arrows next to the names 






Figure 3.20. A hypothetical model on how LCA influences lipid metabolism in “old” NQ cells. 
The model is based on mass spectrometric lipidomics of purified NQ cells that were recovered 
from yeast cultured for 14 days and longer under CR conditions in 0.2% glucose. From the data 
of lipidomic analysis, I inferred that LCA does not alter the concentrations of lipids in “old” NQ 
cells limited in calorie supply. 
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          Taken together, my findings imply that the pattern of age-related changes in lipid 
concentrations seen in Q and NQ cells treated with LCA under CR conditions differs 
substantially from the pattern observed in Q and NQ cells subjected to CR in the absence of 
LCA. Thus, it seems that there are at least two different ways of delaying yeast chronological 
aging by altering lipid metabolism and transport in Q and NQ cells; these two ways are outlined 
in Figures 2.17-2.20 and 3.15-3.20.    
          Future studies will address the key question of which alterations in lipid concentrations 
observed in Q and NQ cells are important for the ability of LCA to delay aging of these cell 
populations under CR conditions. Of note, it is possible that some of these alterations just 
coincide with the progress of chronological aging. To address this challenging question, it will be 
necessary to examine how single-gene mutations eliminating enzymes that accelerate individual 
reactions of lipid metabolism in yeast (Figures 3.15 – 3.20) influence the efficiency with which 
LCA delays yeast chronological aging under CR conditions. Moreover, a challenge remains to 
understand how the alterations of lipid concentrations seen in chronologically aging Q and NQ 
cells treated with LCA delay their aging under CR conditions. It is conceivable that, by 
stimulating the incorporation of fatty acids into TAG, LCA may protect yeast cells from an age-
related form of cell death called liponecrosis [35, 36].   
 73 
4 Lack of the nutrient-sensing protein kinase Tor1, a pro-aging master regulator, 




 The nutrient-sensing protein kinase Tor1 is a longevity-shortening master regulator [1, 2, 
5]. In yeast, Tor1 is known to activate the pro-aging process of protein synthesis in the cytosol 
and also to inhibit such anti-aging processes as transcription of numerous stress-response genes, 
autophagy and protein synthesis in mitochondria [1, 2, 5, 20, 21]. Tor1 can modulate all these 
longevity-defining cellular processes and accelerate chronological aging only under non-CR 
conditions [1, 2, 5]. In studies described in this Chapter of my thesis, I used Percoll density 
gradient centrifugation to separate quiescent (Q) and non-quiescent (NQ) cells of chronologically 
aging yeast. The Q and NQ populations of cells were purified from wild-type cells as well as 
from tor1Δ mutant cells lacking Tor1. These cells were cultured under non-CR conditions on 2% 
glucose without LCA. With the help of quantitative mass spectrometry, I monitored how the 
tor1Δ mutation influences age-related changes in the lipid composition of purified populations of 
Q and NQ yeast grown under non-CR conditions. My findings imply that the tor1Δ mutation, 
which extends yeast chronological lifespan, causes a remodeling of lipid metabolism and 
transport in both Q and NQ cells under non-CR conditions. Based on these findings, I propose a 
working hypothesis on how Tor1 can accelerate chronological aging of yeast cells by altering 




4.2 Materials and Methods 
Yeast strains, media and growth conditions 
The wild-type strain Saccharomyces cerevisiae BY4742 (MATα his3∆1 leu2∆0 lys2∆0 
ura3∆0) and the single-gene-deletion mutant strain tor1Δ (MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 
tor1::kanMX4) from Thermo Scientific/Open Biosystems were grown in YEP medium (1% yeast 
extract, 2% peptone; both from Fisher Scientific; #BP1422-2 and #BP1420-2, respectively) 
initially containing 2% glucose (#D16-10; Fisher Scientific) as carbon source. Cells were 
cultured at 30oC with rotational shaking at 200 rpm in Erlenmeyer flasks at a “flask 
volume/medium volume” ratio of 5:1. 
Separation of Q and NQ cells by centrifugation in Percoll density gradient 
1 mL of 1.5 M NaCl (#S7653; Sigma) was placed into a 50-mL Falcon tube, and 8 mL of 
the Percoll solution (#P1644; Sigma) was added to this tube. The NaCl and Percoll solution was 
then mixed by pipetting. To form two Percoll density gradients, 4 mL of the NaCl/Percoll 
mixture was put into each of the two polyallomer tubes for an MLS-50 rotor for an Optima MAX 
ultracentrifuge (all from Beckman Coulter). The tubes were centrifuged at 25,000 × g (16,000 
rpm) for 15 min at 4oC in an Optima MAX ultracentrifuge. A sample of yeast cells were taken 
from a culture at a certain time point. A fraction of the sample was diluted in order to determine 
the total number of cells per mL of culture using a hemacytometer (#0267110; Fisher Scientific). 
For each Percoll density gradient, 1  109 yeast cells were placed into a 15-mL Falcon tube and 
pelleted by centrifugation at 5,000 rpm for 7 min at room temperature in a Centra CL2 clinical 
centrifuge (Thermo IEC). Pelleted cells were resuspended in 500 μL of 50 mM Tris/HCl buffer 
(pH 7.5), overlaid onto the preformed gradient with a syringe and needle to avoid disrupting the 
gradient, and centrifuged at 2,300 × g (5,000 rpm) for 30 min at 25oC in an Optima MAX 
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ultracentrifuge. The upper and lower fractions of cells were removed with a micropipette, 
discarding the gradient with no visible band of cells and Percoll was removed by washing cells 
twice with 50 mM Tris/HCl buffer (pH 7.5) and cells were resuspended in 1 mL of 50 mM 
Tris/HCl buffer (pH 7.5) for cell counts and preparation for freezing of the cell pellet.  
 
Cell number measurement of Q and NQ cells separated by centrifugation in Percoll density 
gradient and preparation of pellet for storage until lipid extraction 
A 50 µL aliquot of the upper or lower fraction of cells recovered and washed from the 
Percoll gradient were diluted in order to determine the total number of cells per fraction using a 
hemacytometer (#0267110; Fisher Scientific). 10 µL of serial dilutions (1:10 to 1:103) of cells 
were applied to the hemacytometer, where each large square is calibrated to hold 0.1 µL. The 
number of cells in 4 large squares was then counted and an average was taken in order to ensure 
greater accuracy. The concentration of cells was calculated as follows: number of cells per large 
square  dilution factor × 10 × 1,000 = total number of cells per mL of fraction. The remaining 
950 µL of the cell aliquots were washed twice with 155 mM ammonium bicarbonate (pH 8.0) in 
preparation for the freezing of the cell pellet at -80ᴼC until the lipid extraction.  
 
Lipid extraction from purified populations of Q and NQ cells 
The lipid extraction of purified populations of quiescent and non-quiescent cells used 
Richard et al.’s modified version of Bligh and Dyer’s lipid purification and extraction protocol 
[31]. The pelleted cell fractions kept at -80ᴼC were thawed on ice before being resuspended in 
1mL of cold nanopure water. The volume that contained 5 × 107 cells of each fraction was 
transferred to the appropriate 15-mL high-strength glass screw top centrifuge tube with a Teflon 
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lined cap (#0556912; Fisher Scientific). The volume of each sample was topped off to 1 mL with 
cold nanopure water. To each tube the following was added: 20 µL of the internal standard mix 
prepared in Chromasolv HPLC (>99.9%) chloroform (Sigma-Aldrich) (Table 4.1), 800 uL of 
425-600 µM acid-washed glass beads to break open the cells (#G8772; Sigma-Aldrich) and 3 
mL of a Chromasolv HPLC (>99.9%) chloroform: methanol mixture (both from Sigma-Aldrich) 
at a 17:1 ratio. The samples were then vortexed vigorously for 2 hours at 4ᴼC. At room 
temperature, the samples were then centrifuged in a Centra CL2 clinical centrifuge for 5 minutes 
separating the upper aqueous and lower organic phase which contained nonpolar lipids TAG, 
PC, PE and PG. The lower organic layer was transferred to another labelled 15 mL glass high-
strength centrifuge tube using a glass Pasteur pipette with careful attention not to disrupt the 
glass beads or upper aqueous phase. 1.5 mL of 2:1 chloroform: methanol solution was added to 
the remaining upper aqueous phase allowing the separation of polar lipids PA, PS, PI and CL. 
The samples were again vortexed vigorously at 4ᴼC for 1 hour. The non-polar organic band was 
kept at 4ᴼC for the duration of the second vortexing. At the end of 1 hour, the samples were 
again centrifuged for 5 minutes at 3,000 rpm and the lower organic phase was separated and 
added to the corresponding non-polar organic phase with a glass Pasteur pipette. With both lower 
organic phases combined, the solvent was evaporated off by nitrogen gas flow. Once all solvent 
was evaporated, the remaining lipid film was dissolved and resuspended in 100 µL of 1:2 
chloroform: methanol and immediately transferred into 2 mL glass vials with Teflon screw tops 
to avoid evaporation until samples were analysed by mass spectrometry. Samples were then 







Table 4.1: Internal standard mix composition (modified from reference [31]) 
 
Internal Standards CL, PA, PE, PG, PS and PC are all from Avanti Polar Lipid, Alabaster, AL, 
USA. TAG Internal standard originates from Larodan, Malmo, Sweden. 
 
Lipid identification and quantitation of Q and NQ cells using mass spectrometry 
Samples were diluted 1:1 with 1:2 chloroform: methanol and 0.1% ammonium hydroxide 
for improved ionization efficiency. Samples were injected one at a time using a Thermo Orbitrap 
Velos Mass Spectrometer equipped with HESI-II ion source (Thermo Scientific) at a flow rate of 
5 µL/ minute. The instrument settings for the Orbitrap used the optimized settings listed in 
Richard’s et al.’s tune file (Table 4.2).  
Table 4.2: Thermo Orbitrap Velos mass spectrometer’s tune file instrument settings (from 
reference [31]) 
 
Instrument polarity Positive Negative 
Source voltage (kV) 3.9 4 
Capillary temperature (ᴼC) 275 275 
Sheath gas flow 5 5 
Aux gas flow 1 1 
FT-MS injection time (ms) 100 500 










number double bonds 
on fatty acid chain) 








in mix                    
(mg/µL) 
Negative 
CL 14:0 / 14:0 / 14:0 /14:0 1274.9000 619.4157 0.10 
FFA 19:0 298.2872 297.2711 0.02 
PA 14:0 / 14:0 614.3920 591.4026 0.10 
PE 14:0 / 14:0 635.4526 634.4448 0.10 
PG 14:0 / 14:0 688.4290 665.4394 0.10 
PS 14:0 / 14:0 701.4240 678.4271 0.02 
Positive TAG 13:0 / 13:0 / 13:0 680.5955 698.6299 0.10 PC 13:0 / 13:0 649.4683 650.4761 0.10 
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Data was acquired according to the Instrument Method for data-dependent acquisition for 
5 minutes in both positive and negative mode by the FTMS analyser at a resolution of 100,000 
for both MS and MS/MS data (Table 4.3). 
 
Table 4.3: Instrument method for data-dependent acquisition (from reference [31]) 
 
Acquisition time                                  5 minutes ( with a 0.25 minute delay) 
Instrument polarity Positive Negative 




















































Between each sample, the line was flushed with 1:2 chloroform: methanol until the 
background ion detection steadied and returned back into the baseline level. Diluted internal 
standard mix was injected multiple times throughout the acquisition to ensure no sensitivity loss 
throughout the run. 
Once all data was acquired, raw files were converted to open mzXML format using 
ProteoWizard MSConvert software (http://proteowizard.sourceforge.net/), the file format used 
by the Lipid Identification Software LipidXplorer (https://wiki.mpi-cbg.de/lipidx/Main_Page). 
Data files were then imported into the software, using the following settings (Table 4.4), and all 
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lipids in the following lipids classes: PA, PC, PE, PI, PS, CL and TAG, were identified with the 
help of Molecular Fragmentation Query Language (MFQL) files. MFQL files were obtained 
from the LipidXplorer page listed above and aided in the identification of lipids by their m/z 
ratio as well as their fragmentation patterns.  
LipidXplorer’s output data was then opened under a Microsoft Excel file and all detected 
lipids were quantified by comparison with the intensity of the corresponding lipid class’ internal 
standard’s known concentration in the sample. Each quantified lipid had a corresponding internal 
standard from the same lipid class, allowing the calculation of molar percentage of each 
identified lipid species and therefore lipid class.  
 
Table 4.4 Lipid identification by LipidXplorer import settings for data acquired under 
positive and negative mode. (From reference [31])  
 
 Positive Mode Negative Mode 
Selection Window (Da) 
Time Range (sec.) 
Calibration masses 
             MS 
             MS/MS 
m/z range (m/z-m/z) 
             MS 
             MS/MS 
Resolution (FMHW) 
             MS 
             MS/MS 
Tolerance (ppm) 
             MS 
             MS/MS 
Resolution Gradient  (res/(m/z)) 
            MS 
            MS/MS 
Minimum Occupation (0<1) 
             MS 
             MS/MS 














































Statistical analysis was performed using Microsoft Excel’s (2010) Analysis ToolPack-
VBA. All data are presented as mean ± SEM. The p values were calculated with the help of 
GraphPad t test calculator using an unpaired two-tailed t test.  
 
4.3 Results 
4.3.1 The tor1Δ mutation alters the intracellular concentrations of CL, a phospholipid 
specific for mitochondria, in Q and NQ cell populations of chronologically aging 
yeast grown under non-CR conditions 
Using quantitative mass spectrometry, I assessed how the tor1Δ mutation influences the 
concentrations of CL in Q and NQ cells of chronologically aging yeast grown under non-CR 
conditions in 2% glucose. I found that this mutation caused the following effects on the cellular 
concentrations of CL: 1) in chronologically “young” Q and NQ cells cultured from 1 to 4 days, 
the tor1Δ mutation significantly increases CL concentration (Figures 4.1 and 4.2, respectively); 
and 2) in chronologically “middle-aged” (cultured from 6 to 11 days) and “old” (cultured for 14 
days and longer) Q and NQ cells, the tor1Δ mutation substantially decreases CL concentration 
(Figures 4.1 and 4.2, respectively). My findings suggest that the ability of the tor1Δ mutation to 
alter cellular concentrations of CL in Q and NQ cells throughout chronological lifespan may be 
responsible in part for the ability of this mutation to delay chronological aging of both these cell 




Figure 4.1. The tor1Δ mutation alters the age-related dynamics of changes in CL concentrations 
within Q cells under non-CR conditions. Cells were cultured in the nutrient-rich YP medium 
initially containing 2% glucose. Q cells were purified from cell cultures recovered on days 1, 4, 
6, 8, 11, 14, 18 or 21 of cell culturing. Extraction of cellular lipids, as well as their mass 
spectrometric identification and quantitation, were carried out as described in Materials and 
Methods. Based on these data, the concentrations of CL were calculated in mol%. Data are 




Figure 4.2. The tor1Δ mutation alters the age-related dynamics of changes in CL concentrations 
within NQ cells under non-CR conditions. Cells were cultured in the nutrient-rich YP medium 
initially containing 2% glucose. NQ cells were purified from cell cultures recovered on days 1, 4, 
6, 8, 11, 14, 18 or 21 of cell culturing. Extraction of cellular lipids, as well as their mass 
spectrometric identification and quantitation, were carried out as described in Materials and 
Methods. Based on these data, the concentrations of CL were calculated in mol%. Data are 
presented as means ± SEM (n = 2; * p < 0.05).  
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4.3.2 The tor1Δ mutation increases the intracellular concentrations of TAG in Q and NQ 
cell populations of chronologically aging yeast grown under non-CR conditions, but 
for a limited period of chronological age 
With the help of quantitative mass spectrometry, I examined how the tor1Δ mutation 
influences the concentrations of TAG in Q and NQ cells of chronologically aging yeast grown 
under non-CR conditions in 2% glucose. I discovered that this mutation caused the following 
effects on the cellular concentrations of TAG: 1) in chronologically “young” Q and NQ cells 
cultured from 1 to 4 days, the tor1Δ mutation does not alter TAG concentration (Figures 4.3 and 
4.4, respectively); 2) during a transition from the “young” to the “middle” chronological age 
(from day 4 to day 6 of culturing), the tor1Δ mutation substantially increases TAG concentration 
in Q and NQ cells (Figures 4.3 and 4.4, respectively); and 3) in chronologically “middle-aged” 
(cultured from 6 to 11 days) and “old” (cultured for 14 days and longer) Q and NQ cells, the 
tor1Δ mutation does not change TAG concentration (Figures 4.3 and 4.4, respectively). These 
observations suggest that the abilities of the tor1Δ mutation to increase the concentrations of 
TAG in Q and NQ cells for a limited period of chronological age, during a transition from the 
“young” to the “middle” chronological age of these cells, may underlie the delay of 
chronological aging for both these cell populations known to be caused by the tor1Δ mutation.    
 
4.3.3 The tor1Δ mutation increases the concentrations of PA only in “old” Q and NQ cells 
of chronologically aging yeast grown under non-CR conditions 




Figure 4.3. The tor1Δ mutation increases TAG concentration within Q cells under non-CR 
conditions for a limited period of chronological age, during a transition from the “young” to the 
“middle” chronological age (from day 4 to day 6 of culturing). Cells were cultured in the 
nutrient-rich YP medium initially containing 2% glucose. Q cells were purified from cell cultures 
recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as described in 
Materials and Methods. Based on these data, the concentrations of TAG were calculated in 
mol%. Data are presented as means ± SEM (n = 2; * p < 0.05).  
 
 
Figure 4.4. The tor1Δ mutation increases TAG concentration within NQ cells under non-CR 
conditions for a limited period of chronological age, during a transition from the “young” to the 
“middle” chronological age (from day 4 to day 6 of culturing). Cells were cultured in the 
nutrient-rich YP medium initially containing 2% glucose. NQ cells were purified from cell 
cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell culturing. Extraction of cellular 
lipids, as well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods. Based on these data, the concentrations of TAG were 
calculated in mol%. Data are presented as means ± SEM (n = 2; * p < 0.05).  
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concentrations of PA in Q and NQ cells of chronologically aging yeast grown under non-CR 
conditions in 2% glucose. I found that this mutation does not alter the concentrations of PA in 
“young” and “middle-aged” Q and NQ cells of chronologically aging yeast grown under non-CR 
conditions on 2% glucose (Figures 4.5 and 4.6, respectively). However, the tor1Δ mutation 
significantly increases the concentrations of PA in “old” (cultured for 14 days and longer) Q and 
NQ cells of chronologically aging yeast grown under non-CR conditions (Figures 4.5 and 4.6, 
respectively). My findings suggest that the abilities of the tor1Δ mutation to increase the 
concentrations of PA only in chronologically “old” Q and NQ cells may cause the significant 
extensions of their longevities known to be elicited by the tor1Δ mutation.   
 
Figure 4.5. The tor1Δ mutation increases the concentrations of PA only in “old” Q cells of 
chronologically aging yeast grown under non-CR conditions. Cells were cultured in the nutrient-
rich YP medium initially containing 2% glucose. Q cells were purified from cell cultures 
recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as described in 
Materials and Methods. Based on these data, the concentrations of PA were calculated in mol%. 





Figure 4.6. The tor1Δ mutation increases the concentrations of PA only in “old” NQ cells of 
chronologically aging yeast grown under non-CR conditions. Cells were cultured in the nutrient-
rich YP medium initially containing 2% glucose. NQ cells were purified from cell cultures 
recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as described in 
Materials and Methods. Based on these data, the concentrations of PA were calculated in mol%. 
Data are presented as means ± SEM (n = 2; * p < 0.05). 
 
4.3.4 The tor1Δ mutation increases the concentrations of PS in “young” and “middle-
aged” Q and NQ cells, as well as decreases the concentrations of PI in “young” cells 
of both cell types of chronologically aging yeast grown under non-CR conditions 
Using quantitative mass spectrometry, I assessed the effects of the tor1Δ mutation on the 
concentrations of PS and PI in Q and NQ cells of chronologically aging yeast grown under non-
CR conditions on 2% glucose. I discovered that this mutation caused the following effects on the 
cellular concentrations of PS and PI: 1) in chronologically “young” (cultured from 1 to 6 days) 
and “middle-aged” (cultured from 8 to 11 days) Q and NQ cells, the tor1Δ mutation significantly 
increases the concentrations of PS (Figures 4.7 and 4.8, respectively); 2) in chronologically 
“old” (cultured for 14 days and  
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Figure 4.7. The tor1Δ mutation increases the concentrations of PS in chronologically “young” 
(cultured from 1 to 6 days) and “middle-aged” (cultured from 8 to 11 days) Q cells of 
chronologically aging yeast grown under non-CR conditions. Cells were cultured in the nutrient-
rich YP medium initially containing 2% glucose. Q cells were purified from cell cultures 
recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as described in 
Materials and Methods. Based on these data, the concentrations of PS were calculated in mol%. 




Figure 4.8. The tor1Δ mutation increases the concentrations of PS in chronologically “young” 
(cultured from 1 to 6 days) and “middle-aged” (cultured from 8 to 11 days) NQ cells of 
chronologically aging yeast grown under non-CR conditions. Cells were cultured in the nutrient-
rich YP medium initially containing 2% glucose. NQ cells were purified from cell cultures 
recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as described in 
Materials and Methods. Based on these data, the concentrations of PS were calculated in mol%. 




Figure 4.9. The tor1Δ mutation decreases the concentrations of PI in chronologically “young” 
(cultured from 1 to 4 days) Q cells of chronologically aging yeast grown under non-CR 
conditions. Cells were cultured in the nutrient-rich YP medium initially containing 2% glucose. 
Q cells were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell 
culturing. Extraction of cellular lipids, as well as their mass spectrometric identification and 
quantitation, were carried out as described in Materials and Methods. Based on these data, the 




Figure 4.10. The tor1Δ mutation decreases the concentrations of PI in chronologically “young” 
(cultured from 1 to 4 days) NQ cells of chronologically aging yeast grown under non-CR 
conditions. Cells were cultured in the nutrient-rich YP medium initially containing 2% glucose. 
NQ cells were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell 
culturing. Extraction of cellular lipids, as well as their mass spectrometric identification and 
quantitation, were carried out as described in Materials and Methods. Based on these data, the 
concentrations of PI were calculated in mol%. Data are presented as means ± SEM (n = 2; * p < 
0.05). 
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longer) Q and NQ cells, the tor1Δ mutation does not change PS concentration (Figures 4.7 and 
4.8, respectively); 3) in chronologically “young” (cultured from 1 to 4 days) Q and NQ cells, the 
tor1Δ mutation substantially decreases the concentrations of PI (Figures 4.9 and 4.10, 
respectively); and 4) in chronologically “middle-aged” (cultured from 6 to 11 days) and “old” 
(cultured for 14 days and longer) Q and NQ cells, the tor1Δ mutation does not change PI 
concentration (Figures 4.9 and 4.10, respectively). These findings suggest that the abilities of 
the tor1Δ mutation to increase PS concentrations in “young” and “middle-aged” Q and NQ cells, 
as well its abilities to decrease PI concentrations in “young” cells of both cell types, may be 
responsible in part for the significant delays of aging of Q and NQ cells known to be elicited by 
the tor1Δ mutation.   
  
4.3.5 The tor1Δ mutation increases the concentrations of PE in “middle-aged” Q and NQ 
cells, as well as decreases the concentrations of PC in “middle-aged” and “old” NQ 
cells, of chronologically aging yeast grown under non-CR conditions 
With the help of quantitative mass spectrometry, I examined how the tor1Δ mutation 
influences the concentrations of PE and PC in Q and NQ cells of chronologically aging yeast 
grown under non-CR conditions in 2% glucose. I found that the tor1Δ mutation caused the 
following effects on the cellular concentrations of PE and PC: 1) in chronologically “middle-
aged” (cultured from 8 to 11 days) Q and NQ cells, the tor1Δ mutation significantly increases the 
concentrations of PE (Figures 4.11 and 4.12, respectively); 2) in chronologically “young” 
(cultured from 1 to 6 days) and “old” (cultured for 14 days and longer) Q and NQ cells, the tor1Δ 
mutation does not change PE concentration (Figures 4.11 and 4.12, respectively); 3) the tor1Δ 
mutation does not change PC concentrations in Q cells of any chronological age (Figure 4.13); 
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and 4) the tor1Δ mutation decreases the concentrations of PC in “middle-aged” (cultured from 8 
to 11 days) and “old” (cultured for 14 days and longer) NQ cells (Figure 4.14). My findings 
suggest that the abilities of the tor1Δ mutation to increase the concentrations of PE in “middle-
aged” Q and NQ cells, as well as its abilities to decrease the concentrations of PC in “middle-
aged” and “old” NQ cells, may be responsible in part for the significant delays of aging of Q and 
NQ cells known to be caused by the tor1Δ mutation. 
   
 
Figure 4.11. The tor1Δ mutation increases the concentrations of PE in chronologically “middle-
aged” (cultured from 8 to 11 days) Q cells of chronologically aging yeast grown under non-CR 
conditions. Cells were cultured in the nutrient-rich YP medium initially containing 2% glucose. 
Q cells were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell 
culturing. Extraction of cellular lipids, as well as their mass spectrometric identification and 
quantitation, were carried out as described in Materials and Methods. Based on these data, the 







Figure 4.12. The tor1Δ mutation increases the concentrations of PE in chronologically “middle-
aged” (cultured from 8 to 11 days) NQ cells of chronologically aging yeast grown under non-CR 
conditions. Cells were cultured in the nutrient-rich YP medium initially containing 2% glucose. 
NQ cells were purified from cell cultures recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell 
culturing. Extraction of cellular lipids, as well as their mass spectrometric identification and 
quantitation, were carried out as described in Materials and Methods. Based on these data, the 




Figure 4.13. The tor1Δ mutation does not change PC concentrations in Q cells of any 
chronological age in yeast grown under non-CR conditions. Cells were cultured in the nutrient-
rich YP medium initially containing 2% glucose. Q cells were purified from cell cultures 
recovered on days 1, 4, 6, 8, 11, 14, 18 or 21 of cell culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as described in 
Materials and Methods. Based on these data, the concentrations of PC were calculated in mol%. 
Data are presented as means ± SEM (n = 2). 
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Figure 4.14. The tor1Δ mutation decreases the concentrations of PC in “middle-aged” (cultured 
from 8 to 11 days) and “old” (cultured for 14 days and longer) NQ cells of chronologically aging 
yeast grown under non-CR conditions. Cells were cultured in the nutrient-rich YP medium 
initially containing 2% glucose. NQ cells were purified from cell cultures recovered on days 1, 4, 
6, 8, 11, 14, 18 or 21 of cell culturing. Extraction of cellular lipids, as well as their mass 
spectrometric identification and quantitation, were carried out as described in Materials and 
Methods. Based on these data, the concentrations of PC were calculated in mol%. Data are 
presented as means ± SEM (n = 2; * p < 0.05). 
 
4.4 Discussion 
Studies described in this chapter of my thesis have demonstrated that in yeast cultured 
under non-CR conditions the tor1Δ mutation causes a remodeling of lipid metabolism and 
transport within both Q and NQ cells. My findings imply that the remodeling of lipid dynamics 
elicited by the tor1Δ mutation in each of these cell populations differs substantially from the ones 
observed in Q and NQ cells subjected to CR in the absence of LCA or in Q and NQ cells treated 
with LCA under CR conditions. Based on findings presented in this chapter, I propose a 
hypothetical model on how the tor1Δ mutation, a longevity-extending genetic intervention, may 
delay yeast chronological aging by altering the age-related dynamics of various lipids in Q and 
NQ cells progressing through consecutive stages of the aging process. My model posits the 
following: 1) in “young” Q cells, the tor1Δ mutation increases the concentration of PS and CL, 
perhaps by intensifying their synthesis in the ER and mitochondria, respectively (Figure 4.15); 
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2) in “young” Q cells, the tor1Δ mutation reduces the concentration of PI, perhaps by slowing 
down its synthesis in the ER (Figure 4.15); 3) in “middle-aged” Q cells, the tor1Δ mutation 
elevates the concentrations of TAG, PS and PE, likely by stimulating their synthesis in the ER 
and mitochondria (Figure 4.16); 4) in “middle-aged” Q cells, the tor1Δ mutation decreases the 
concentration of CL, perhaps by slowing down its synthesis in mitochondria (Figure 4.16); 5) in 
“old” Q cells, the tor1Δ mutation increases the concentration of PA, possibly by stimulating its 
formation in the ER (Figure 4.17); 6) in “old” Q cells, the tor1Δ mutation decreases the 
concentration of CL, likely by decelerating its synthesis in mitochondria (Figure 4.17); 7) in 
“young” NQ cells, the tor1Δ mutation increases the concentration of PS and CL, perhaps by 
intensifying their synthesis in the ER and mitochondria, respectively (Figure 4.18); 8) in 
“young” NQ cells, the tor1Δ mutation reduces the concentration of PI, perhaps by slowing down 
its synthesis in the ER (Figure 4.18); 9) in “middle-aged” NQ cells, the tor1Δ mutation elevates 
the concentrations of TAG, PS and PE, likely by stimulating their synthesis in the ER and 
mitochondria (Figure 4.19); 10) in “middle-aged” NQ cells, the tor1Δ mutation decreases the 
concentrations of PC and CL, perhaps by slowing down their synthesis in the ER and 
mitochondria, respectively (Figure 4.19); 11) in “old” NQ cells, the tor1Δ mutation increases the 
concentration of PA, possibly by stimulating its formation in the ER (Figure 4.20); and 12) in 
“old” NQ cells, the tor1Δ mutation decreases the concentration of PC and CL, likely by 
decelerating their synthesis in the ER and mitochondria, respectively (Figure 4.20). 
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Figure 4.15. A hypothetical model on how the tor1Δ mutation alters the metabolism of PS, PI 
and CL in “young” Q cells. The model is based on mass spectrometric lipidomics of purified Q 
cells that were recovered from yeast cultured from 1 to 4 days prior to entry into stationary 
growth phase under non-CR conditions in 2% glucose. From the data of lipidomic analysis, I 
inferred an outline of the rates and efficiencies of lipid metabolism that were increased (thick 
solid arrows) or decreased (thin dashed arrows) by the tor1Δ mutation under non-CR conditions. 
Arrows next to the names of lipid classes denote those of them whose concentrations are 






Figure 4.16. A hypothetical model on how the tor1Δ mutation alters the metabolism of TAG, 
PS, PE and CL in “middle-aged” Q cells. The model is based on mass spectrometric lipidomics 
of purified Q cells that were recovered from yeast cultured from 6 to 11 days under non-CR 
conditions in 2% glucose. From the data of lipidomic analysis, I inferred an outline of the rates 
and efficiencies of lipid metabolism that were increased (thick solid arrows) or decreased (thin 
dashed arrows) by the tor1Δ mutation under non-CR conditions. Arrows next to the names of 
lipid classes denote those of them whose concentrations are elevated (red arrows) or reduced 




Figure 4.17. A hypothetical model on how the tor1Δ mutation alters the metabolism of PA and 
CL in “old” Q cells. The model is based on mass spectrometric lipidomics of purified Q cells that 
were recovered from yeast cultured for 14 days and longer under non-CR conditions in 2% 
glucose. From the data of lipidomic analysis, I inferred an outline of the rates and efficiencies of 
lipid metabolism that were increased (thick solid arrows) or decreased (thin dashed arrows) by 
the tor1Δ mutation under non-CR conditions. Arrows next to the names of lipid classes denote 
those of them whose concentrations are elevated (red arrows) or reduced (blue arrows) by the 





Figure 4.18. A hypothetical model on how the tor1Δ mutation alters the metabolism of PS, PI 
and CL in “young” NQ cells. The model is based on mass spectrometric lipidomics of purified 
NQ cells that were recovered from yeast cultured from 1 to 4 days prior to entry into stationary 
growth phase under non-CR conditions in 2% glucose. From the data of lipidomic analysis, I 
inferred an outline of the rates and efficiencies of lipid metabolism that were increased (thick 
solid arrows) or decreased (thin dashed arrows) by the tor1Δ mutation under non-CR conditions. 
Arrows next to the names of lipid classes denote those of them whose concentrations are 





Figure 4.19. A hypothetical model on how the tor1Δ mutation alters the metabolism of TAG, 
PC, PS, PE and CL in “middle-aged” NQ cells. The model is based on mass spectrometric 
lipidomics of purified NQ cells that were recovered from yeast cultured from 6 to 11 days under 
non-CR conditions on 2% glucose. From the data of lipidomic analysis, I inferred an outline of 
the rates and efficiencies of lipid metabolism that were increased (thick solid arrows) or 
decreased (thin dashed arrows) by the tor1Δ mutation under non-CR conditions. Arrows next to 
the names of lipid classes denote those of them whose concentrations are elevated (red arrows) 
or reduced (blue arrows) by the tor1Δ mutation in cells under non-CR conditions. 




Figure 4.20. A hypothetical model on how the tor1Δ mutation alters the metabolism of PA, PC 
and CL in “old” NQ cells. The model is based on mass spectrometric lipidomics of purified NQ 
cells that were recovered from yeast cultured from 6 to 11 days under non-CR conditions on 2% 
glucose. From the data of lipidomic analysis, I inferred an outline of the rates and efficiencies of 
lipid metabolism that were increased (thick solid arrows) or decreased (thin dashed arrows) by 
the tor1Δ mutation under non-CR conditions. Arrows next to the names of lipid classes denote 
those of them whose concentrations are elevated (red arrows) or reduced (blue arrows) by the 
tor1Δ mutation in cells under non-CR conditions.           
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In sum, my findings imply that the pattern of age-related changes in lipid concentrations 
seen in Q and NQ cells carrying the tor1Δ mutation differs substantially from the patterns 
observed in Q and NQ cells either subjected to CR in the absence of LCA or treated with LCA 
under CR conditions. Thus, it seems that there are at least three different ways of delaying yeast 
chronological aging by altering lipid metabolism and transport in Q and NQ cells; these three 
ways are outlined in Figures 2.17-2.20, 3.15-3.20 and 4.15-4.20.    
          Future studies will address the key question which of the alterations in lipid concentrations 
observed in Q and NQ cells are essential for the ability of the tor1Δ mutation to delay aging of 
these cell populations under non-CR conditions. It is conceivable that some of these alterations 
just coincide with the progress of chronological aging. To address this challenging question, it 
will be necessary to examine how single-gene mutations eliminating enzymes that accelerate 
individual reactions of lipid metabolism in yeast (Figures 4.15 – 4.20) impact the efficiency with 
which the tor1Δ mutation delays yeast chronological aging under non-CR conditions. Moreover, 
a challenge remains to understand how the alterations of lipid concentrations seen in 
chronologically aging Q and NQ cells carrying the tor1Δ mutation delay their aging under non-
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